Â© 2000-2022 QIAGEN. All rights reserved.

Categories	Diseases or Functions Annotation	p-value	Molecules	# Molecules
Immunological Disease,Inflammatory Disease,Organismal Injury and Abnormalities	Immune mediated inflammatory disease	1.36E-47	ADORA2A,AIM2,APOBEC3A,BCL2L14,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EPSTI1,ETV7,FPR2,G0S2,HELZ2,HERC5,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,ITGB8,JAK3,LAG3,LAMP3,MDK,MT1H,MT1X,MT2A,MX1,MX2,NAMPT,NCF1,OASL,PDE4B,PTGES,PTGIR,PTGS2,RSAD2,S100A12,SERPINB2,SIGLEC1,SIGLEC10,SLC1A2,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,WNT5A,XAF1,ZBP1	86
Immunological Disease,Organismal Injury and Abnormalities	Systemic autoimmune syndrome	3.94E-44	ADORA2A,AIM2,APOBEC3A,BCL2L14,CALHM6,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CMPK2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EPSTI1,ETV7,FPR2,G0S2,GBP4,HELZ2,HERC5,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL1A,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAMP3,MDK,MT1H,MT1X,MT2A,MX1,MX2,NAMPT,NCF1,OASL,PDE4B,PTGES,PTGS2,RSAD2,S100A12,SERPINB2,SIGLEC1,SIGLEC10,SLC1A2,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,WNT5A,XAF1,ZBP1	82
Inflammatory Response,Organismal Injury and Abnormalities	Inflammation of organ	1.24E-39	ACOD1,ADGRE1,ADORA2A,AIM2,APOBEC3A,BCL2L14,CA12,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,ENPP2,EPSTI1,EREG,ETV7,FPR2,GBP5,GCH1,HERC5,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,ITGB8,JAK3,LAG3,LAMP3,MDK,MX1,NAMPT,NCF1,OASL,PAX5,PDE4B,PTGES,PTGIR,PTGS2,RSAD2,SIGLEC10,SLC2A6,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,WNT5A,ZBP1	82
Inflammatory Response,Organismal Injury and Abnormalities	Inflammation of body cavity	1.35E-35	ACOD1,ADGRE1,ADORA2A,AIM2,CCL20,CCL4,CCL5,CCL8,CCR7,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,ENPP2,EPSTI1,EREG,FPR2,GBP5,GCH1,HERC5,IDO1,IFIT2,IFIT3,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF7,ISG15,ISG20,ITGB8,JAK3,LAG3,MDK,NAMPT,NCF1,PAX5,PDE4B,PTGES,PTGS2,SIGLEC10,SLC2A6,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,WNT5A,ZBP1	68
Inflammatory Response,Organismal Injury and Abnormalities	Inflammation of absolute anatomical region	1.17E-32	ACOD1,ADGRE1,ADORA2A,AIM2,CA12,CCL20,CCL4,CCL5,CCL8,CCR7,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,ENPP2,EPSTI1,EREG,FPR2,GBP5,GCH1,HERC5,IDO1,IFIT2,IFIT3,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,ITGB8,JAK3,LAG3,MDK,NAMPT,NCF1,PAX5,PDE4B,PTGES,PTGS2,SIGLEC10,SLC2A6,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,WNT5A,ZBP1	70
Immunological Disease,Inflammatory Disease,Organismal Injury and Abnormalities	Lupus erythematosus	1.60E-30	AIM2,APOBEC3A,BCL2L14,CD80,CFB,CMPK2,CXCL10,CYP2E1,DDX58,EPSTI1,ETV7,HERC5,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL1B,IL2RA,IRF7,ISG15,ISG20,JAK3,LAMP3,MT1H,MT1X,MT2A,MX1,MX2,NCF1,OASL,PTGS2,RSAD2,SERPINB2,SIGLEC1,SOCS3,STAT4,TNFSF10,XAF1,ZBP1	43
Antimicrobial Response,Inflammatory Response	Antimicrobial response	2.27E-30	ACOD1,AIM2,APOBEC3A,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CLEC4D,CLEC4E,CXCL10,CXCL13,CXCL8,DDX58,FPR2,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL1B,IL27,IRF7,ISG15,ISG20,ITGB8,MX1,MX2,NCF1,OASL,PLAC8,RSAD2,S100A12,SOCS3,ZBP1	38
Immunological Disease,Inflammatory Disease,Organismal Injury and Abnormalities	Systemic lupus erythematosus	6.82E-30	AIM2,APOBEC3A,BCL2L14,CD80,CFB,CMPK2,CXCL10,CYP2E1,DDX58,EPSTI1,ETV7,HERC5,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL1B,IL2RA,IRF7,ISG15,ISG20,JAK3,LAMP3,MT1H,MT1X,MT2A,MX1,MX2,NCF1,OASL,PTGS2,RSAD2,SERPINB2,SIGLEC1,SOCS3,STAT4,TNFSF10,XAF1,ZBP1	42
Cellular Movement	Cell movement of blood cells	1.57E-29	ADAM19,ADORA2A,AIM2,C1QTNF1,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CD80,CFB,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,ENPP2,FPR2,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,JAK3,LAG3,MCOLN2,MDK,MYO1G,NCF1,PDE4B,PDPN,PTGES,PTGIR,PTGS2,S100A12,SLAMF1,SNAI1,SOCS3,THBS1,TNFAIP6,TNFSF10,VCAN,WNT5A,ZBP1	58
Cellular Movement,Immune Cell Trafficking	Leukocyte migration	8.29E-29	ADAM19,ADORA2A,AIM2,C1QTNF1,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CD80,CFB,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,ENPP2,FPR2,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,JAK3,LAG3,MCOLN2,MDK,MYO1G,NCF1,PDE4B,PDPN,PTGES,PTGIR,PTGS2,S100A12,SLAMF1,SNAI1,SOCS3,THBS1,TNFAIP6,TNFSF10,VCAN,WNT5A	57
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cell movement of leukocytes	3.57E-28	ADAM19,ADORA2A,AIM2,C1QTNF1,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CD80,CFB,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,ENPP2,FPR2,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,JAK3,LAG3,MDK,MYO1G,NCF1,PDE4B,PDPN,PTGES,PTGIR,PTGS2,S100A12,SLAMF1,SOCS3,THBS1,TNFAIP6,TNFSF10,VCAN,WNT5A	54
Infectious Diseases,Organismal Injury and Abnormalities	COVID-19	1.07E-27	ADORA2A,CCL20,CCL4,CCL5,CCL8,CD38,CFB,CXCL1,CXCL10,CXCL2,CXCL8,EHF,EPSTI1,GCH1,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL1A,IL1B,IL27,IRF7,ISG15,JAK3,KCNJ5,MX1,MX2,NAMPT,PDE4B,PLAC8,PTGS2,RSAD2,S100A12,SIGLEC1,TNFSF10,VCAN,XAF1	40
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function	Activation of blood cells	1.11E-27	ADORA2A,AIM2,C1QTNF1,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CD80,CLEC4D,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL3,CXCL5,CXCL8,DDX58,FPR2,HSH2D,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF4,JAK3,LAG3,NAMPT,NCF1,PAX5,PDPN,PTGES,PTGIR,PTGS2,S100A12,SIGLEC1,SIGLEC10,SLAMF1,SOCS2,STAT4,THBS1,TNFSF10,TRAF1,VCAN,WNT5A	51
Dermatological Diseases and Conditions,Organismal Injury and Abnormalities	Psoriasis	1.79E-27	APOBEC3A,CALHM6,CCL20,CCL5,CXCL1,CXCL10,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EPSTI1,G0S2,IDO1,IFI27,IFI44L,IFIT1,IFIT3,IFITM1,IL12B,IL1A,IL1B,IL27,IL2RA,IRF7,ISG15,ISG20,JAK3,LAD1,LAMP3,MT1X,MX1,NAMPT,OASL,PDE4B,PTGS2,RSAD2,S100A12,SERPINB2,SOCS2,SOCS3,TNFAIP6,WNT5A	43
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Activation of leukocytes	3.10E-26	ADORA2A,AIM2,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CD80,CLEC4D,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL3,CXCL5,CXCL8,DDX58,FPR2,HSH2D,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF4,JAK3,LAG3,NAMPT,NCF1,PAX5,PTGES,PTGS2,S100A12,SIGLEC1,SIGLEC10,SLAMF1,SOCS2,STAT4,THBS1,TNFSF10,TRAF1,VCAN,WNT5A	48
Cell-To-Cell Signaling and Interaction	Activation of cells	3.55E-26	ADORA2A,AIM2,C1QTNF1,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CD80,CLEC4D,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,FPR2,HSH2D,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF4,IRF7,JAK3,LAG3,NAMPT,NCF1,PAX5,PDPN,PTGES,PTGIR,PTGS2,S100A12,SIGLEC1,SIGLEC10,SLAMF1,SNAI1,SOCS2,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,VCAN,WNT5A,ZBP1	56
Antimicrobial Response,Inflammatory Response	Antiviral response	4.95E-26	ACOD1,AIM2,APOBEC3A,CCL19,CCL4,CCL5,CCL8,CCR7,CXCL10,DDX58,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL1B,IL27,IRF7,ISG15,ISG20,ITGB8,MX1,MX2,OASL,RSAD2,SOCS3,ZBP1	29
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Lymphocyte migration	6.74E-25	ADORA2A,AIM2,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD80,CRLF2,CXCL1,CXCL10,CXCL13,CXCL3,CXCL8,DDX58,ENPP2,IL12B,IL15RA,IL1A,IL1B,IL2RA,IL7R,IRF4,IRF7,JAK3,LAG3,MDK,MYO1G,PTGS2,SOCS3,THBS1,TNFSF10,WNT5A	36
Hematological System Development and Function,Tissue Morphology	Quantity of leukocytes	7.57E-25	ADORA2A,AIM2,CALHM6,CCL19,CCL20,CCL4,CCL5,CCR7,CD38,CD70,CD80,CLEC4D,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL8,DDX58,EBI3,FPR2,HESX1,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,ITGB8,JAK3,LAG3,MDK,MYO1G,PAX5,PDE4B,PLAC8,PTGES,PTGIR,PTGS2,SERPINB2,SIGLEC1,SIGLEC10,SOCS3,STAT4,THBS1,TNFSF10,TRAF1,VCAN,WNT5A	54
Cellular Movement	Cell movement of myeloid cells	1.77E-24	ADAM19,ADORA2A,AIM2,C1QTNF1,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CFB,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF7,JAK3,MDK,NCF1,PDE4B,PTGES,PTGIR,PTGS2,S100A12,SLAMF1,SOCS3,THBS1,TNFAIP6,VCAN,WNT5A,ZBP1	43
Inflammatory Disease,Organismal Injury and Abnormalities	Chronic inflammatory disorder	1.82E-24	ADORA2A,CA12,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,EREG,FPR2,G0S2,HELZ2,HS3ST3B1,IDO1,IL12B,IL1A,IL1B,IL2RA,IL7R,ITGB8,JAK3,KCNA2,LAG3,MDK,NAMPT,NCF1,NCF1C,PAX5,PDE4B,PTGES,PTGS2,S100A12,SLAMF1,SLC1A2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,WNT5A,ZBP1	57
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Cell movement of phagocytes	3.51E-24	ADAM19,ADORA2A,AIM2,C1QTNF1,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD38,CD80,CFB,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF7,JAK3,MDK,NCF1,PDE4B,PDPN,PTGES,PTGS2,S100A12,SLAMF1,SOCS3,THBS1,TNFAIP6,VCAN,WNT5A	43
Connective Tissue Disorders,Inflammatory Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Rheumatic Disease	4.26E-24	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,EBI3,ENPP2,FPR2,G0S2,HELZ2,IDO1,IL12B,IL15RA,IL1A,IL1B,IL2RA,IL7R,ITGB8,JAK3,MDK,MN1,NAMPT,NCF1,PAX5,PDE4B,PTGES,PTGIR,PTGS2,S100A12,SERPINB2,SLC1A2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,WNT5A	55
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cell movement of lymphocytes	4.89E-24	ADORA2A,AIM2,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD80,CRLF2,CXCL1,CXCL10,CXCL13,CXCL3,CXCL8,DDX58,ENPP2,IL12B,IL15RA,IL1A,IL1B,IL2RA,IL7R,IRF4,IRF7,JAK3,LAG3,MDK,MYO1G,PTGES,PTGS2,SOCS3,THBS1,TNFSF10,WNT5A	37
Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities	Type 1 interferonopathy	1.45E-23	CMPK2,EPSTI1,HERC5,IFI27,IFI44L,IFIT1,IRF7,ISG15,JAK3,LAMP3,MX1,OASL,RSAD2,SIGLEC1	14
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cell movement of mononuclear leukocytes	1.52E-23	ADORA2A,AIM2,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD80,CRLF2,CXCL1,CXCL10,CXCL13,CXCL3,CXCL8,DDX58,ENPP2,FPR2,IL12B,IL15RA,IL1A,IL1B,IL2RA,IL7R,IRF4,IRF7,JAK3,LAG3,MDK,MYO1G,PTGES,PTGS2,S100A12,SOCS3,THBS1,TNFSF10,WNT5A	39
Cellular Movement	Cellular infiltration by blood cells	1.63E-23	ADAM19,ADORA2A,AIM2,C1QTNF1,CCL19,CCL4,CCL5,CCR7,CD38,CFB,CLEC4E,CRLF2,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF7,JAK3,LAG3,MDK,NCF1,PTGES,PTGIR,PTGS2,SOCS3,THBS1,TNFSF10,WNT5A,ZBP1	38
Hematological System Development and Function,Tissue Morphology	Quantity of blood cells	2.28E-23	ADORA2A,AIM2,CALHM6,CCL19,CCL20,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CLEC4D,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL8,DDX58,EBI3,FPR2,HESX1,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,ITGB8,JAK3,LAG3,MDK,MYO1G,PAX5,PDE4B,PLAC8,PTGES,PTGIR,PTGS2,SERPINB2,SIGLEC1,SIGLEC10,SOCS3,STAT4,THBS1,TNFSF10,TRAF1,VCAN,WNT5A	55
Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities	ATAD3A-related type I interferonopathy	4.36E-23	CMPK2,EPSTI1,HERC5,IFI27,IFI44L,IFIT1,IRF7,ISG15,LAMP3,MX1,OASL,RSAD2,SIGLEC1	13
Cellular Movement	Cellular infiltration by myeloid cells	5.02E-23	ADAM19,ADORA2A,AIM2,C1QTNF1,CCL19,CCL4,CCL5,CCR7,CFB,CLEC4E,CRLF2,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF7,JAK3,MDK,NCF1,PTGES,PTGIR,PTGS2,SOCS3,WNT5A,ZBP1	33
Cellular Movement	Cellular infiltration	5.70E-23	ADAM19,ADORA2A,AIM2,C1QTNF1,CCL19,CCL4,CCL5,CCR7,CD38,CFB,CLEC4E,CRLF2,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF7,JAK3,LAG3,MDK,NCF1,PTGES,PTGIR,PTGS2,SOCS2,SOCS3,THBS1,TNFSF10,WNT5A,ZBP1	39
Connective Tissue Disorders,Immunological Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Rheumatoid arthritis	6.57E-23	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,G0S2,HELZ2,IL1A,IL1B,IL2RA,IL7R,JAK3,MDK,NAMPT,NCF1,PDE4B,PTGES,PTGS2,S100A12,SLC1A2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,WNT5A	44
Gastrointestinal Disease,Inflammatory Response,Organismal Injury and Abnormalities	Inflammation of gastrointestinal tract	7.52E-23	ACOD1,ADGRE1,ADORA2A,APOBEC3A,CCL5,CCR7,CD80,CEMIP,CFB,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,EBI3,ENPP2,EREG,FPR2,GBP5,GCH1,IDO1,IL12B,IL1A,IL1B,IL2RA,ITGB8,JAK3,NCF1,PAX5,PDE4B,PTGS2,SOCS3,STAT4,TNFAIP6,ZBP1	40
Gastrointestinal Disease,Organismal Injury and Abnormalities	Abnormality of large intestine	1.25E-22	ACOD1,ADGRE1,ADORA2A,CCL5,CD80,CEMIP,CFB,CLEC4E,CRLF2,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,EBI3,ENPP2,EREG,FPR2,GBP5,GCH1,IDO1,IL12B,IL1A,IL1B,IL2RA,ITGB8,JAK3,MDK,NCF1,PAX5,PDE4B,PTGS2,SOCS3,STAT4,WNT5A,ZBP1	38
Gastrointestinal Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	Colitis	2.48E-22	ACOD1,ADGRE1,ADORA2A,CCL5,CD80,CEMIP,CFB,CLEC4E,CRLF2,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,EBI3,ENPP2,EREG,FPR2,GBP5,GCH1,IDO1,IL12B,IL1A,IL1B,IL2RA,ITGB8,JAK3,NCF1,PAX5,PDE4B,PTGS2,SOCS3,STAT4,ZBP1	36
Cell-mediated Immune Response,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cell movement of T lymphocytes	3.03E-22	ADORA2A,AIM2,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CRLF2,CXCL1,CXCL10,CXCL13,CXCL8,ENPP2,IL12B,IL15RA,IL1A,IL1B,IL2RA,IRF7,JAK3,LAG3,MDK,PTGS2,SOCS3,THBS1,TNFSF10,WNT5A	29
Connective Tissue Disorders,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Inflammation of joint	3.67E-22	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,ENPP2,FPR2,G0S2,HELZ2,IL12B,IL15RA,IL1A,IL1B,IL2RA,IL7R,JAK3,MDK,MN1,NAMPT,NCF1,PAX5,PDE4B,PTGES,PTGIR,PTGS2,S100A12,SERPINB2,SLC1A2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,WNT5A	51
Gastrointestinal Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	Enteritis	8.83E-22	ACOD1,ADGRE1,ADORA2A,CCL5,CCR7,CD80,CEMIP,CFB,CLEC4E,CRLF2,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,EBI3,ENPP2,EREG,FPR2,GBP5,GCH1,IDO1,IL12B,IL1A,IL1B,IL2RA,ITGB8,JAK3,NCF1,PAX5,PDE4B,PTGS2,SOCS3,STAT4,ZBP1	37
Cellular Movement	Cell movement	9.98E-22	ADAM19,ADORA2A,AIM2,ANGPTL4,C1QTNF1,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CD80,CEMIP,CFB,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,EBI3,EHF,ENPP2,EREG,FPR2,FSIP1,IDO1,IFIT2,IFITM1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ITGB8,JAK3,LAG3,MCOLN2,MDK,MT1F,MX1,MYO1G,NAMPT,NCF1,NKX3-1,NSUN7,PAX5,PDE4B,PDPN,PLXNA4,PTGES,PTGIR,PTGS2,S100A12,SERPINB2,SLAMF1,SLC1A2,SNAI1,SOCS2,SOCS3,THBS1,TNFAIP6,TNFSF10,VCAN,WFDC21P,WNT5A,ZBP1	79
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cellular infiltration by leukocytes	1.35E-21	ADAM19,ADORA2A,AIM2,C1QTNF1,CCL19,CCL4,CCL5,CCR7,CD38,CFB,CRLF2,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF7,JAK3,LAG3,MDK,NCF1,PTGES,PTGIR,PTGS2,SOCS3,THBS1,TNFSF10,WNT5A	36
Cellular Development,Cellular Growth and Proliferation	Proliferation of blood cells	1.79E-21	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CFB,CLEC4D,CRLF2,CXCL10,CXCL2,CXCL3,CXCL8,EBI3,GCH1,HSH2D,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,ISG20,JAK3,LAG3,MDK,PTGS2,SIGLEC1,SIGLEC10,SLAMF1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFSF10,TRAF1,WNT5A	47
Cellular Movement	Migration of cells	7.26E-21	ADAM19,ADORA2A,AIM2,ANGPTL4,C1QTNF1,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CD80,CEMIP,CFB,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,EBI3,EHF,ENPP2,EREG,FPR2,FSIP1,IDO1,IFIT2,IFITM1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ITGB8,JAK3,LAG3,MCOLN2,MDK,MT1F,MYO1G,NAMPT,NCF1,NKX3-1,PAX5,PDE4B,PDPN,PTGES,PTGIR,PTGS2,S100A12,SERPINB2,SLAMF1,SLC1A2,SNAI1,SOCS3,THBS1,TNFAIP6,TNFSF10,VCAN,WFDC21P,WNT5A	74
Infectious Diseases,Organismal Injury and Abnormalities	Viral Infection	7.57E-21	ADORA2A,CCL20,CCL4,CCL5,CCL8,CCR7,CD38,CD70,CD80,CFB,CLEC4E,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EHF,EPSTI1,GBP5,GCH1,GFPT2,HERC5,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,KCNJ5,MAP1LC3A,MT1X,MT2A,MX1,MX2,NAMPT,NCF1,OASL,PDE4B,PLAC8,PTGS2,RSAD2,S100A12,SIGLEC1,SLAMF1,SOCS2,SOCS3,STAT4,TNFSF10,VCAN,XAF1,ZBP1	67
Inflammatory Response	Inflammatory response	8.21E-21	ACOD1,ADORA2A,ANGPTL4,APOL3,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IDO1,IL12B,IL1A,IL1B,IL27,IL2RA,ISG15,MDK,NAMPT,NCF1,NKG7,PDE4B,PTGES,PTGS2,S100A12,SLAMF1,SOCS3,STAT4,THBS1,TNFAIP6,WNT5A,ZBP1	45
Dermatological Diseases and Conditions,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	Dermatitis	9.03E-21	AIM2,APOBEC3A,BCL2L14,CCL20,CCL23,CCL5,CCR7,CD80,CRLF2,CXCL13,CXCL8,EREG,ETV7,IFI27,IFI44L,IFIT1,IFIT3,IL1A,IL1B,IL27,IL2RA,ISG15,JAK3,LAMP3,MX1,OASL,PDE4B,PTGIR,PTGS2,RSAD2,SOCS2,SOCS3,THBS1,TNFSF10,ZBP1	35
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Homing of leukocytes	1.78E-20	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD38,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,ENPP2,FPR2,IL12B,IL1A,IL1B,JAK3,MDK,PDE4B,PTGES,S100A12,SLAMF1,SOCS3,THBS1,TNFAIP6,WNT5A	31
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cell movement of granulocytes	3.46E-20	ADORA2A,AIM2,CCL19,CCL23,CCL4,CCL5,CCL8,CCR7,CFB,CRLF2,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL12B,IL1A,IL1B,IL27,IL2RA,IRF7,JAK3,MDK,NCF1,PDE4B,PTGIR,PTGS2,S100A12,SOCS3,TNFAIP6	32
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cellular infiltration by granulocytes	3.93E-20	ADORA2A,AIM2,CCL19,CCL4,CCL5,CCR7,CFB,CRLF2,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL12B,IL1A,IL1B,IL27,IL2RA,IRF7,JAK3,MDK,NCF1,PTGIR,PTGS2,SOCS3	26
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Activation of mononuclear leukocytes	5.31E-20	ADORA2A,AIM2,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CD80,CXCL10,CXCL8,DDX58,HSH2D,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF4,JAK3,LAG3,NAMPT,NCF1,PAX5,S100A12,SIGLEC1,SIGLEC10,SLAMF1,SOCS2,STAT4,THBS1,TNFSF10,TRAF1,WNT5A	35
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Activation of T lymphocytes	6.07E-20	ADORA2A,AIM2,CCL4,CCL5,CCL8,CD226,CD38,CD80,CXCL10,CXCL8,DDX58,HSH2D,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF4,JAK3,LAG3,NAMPT,NCF1,SIGLEC1,SIGLEC10,SLAMF1,STAT4,THBS1,TNFSF10,TRAF1,WNT5A	31
Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Non-traumatic arthropathy	6.45E-20	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,G0S2,HELZ2,IL1A,IL1B,IL2RA,IL7R,JAK3,MDK,MN1,NAMPT,NCF1,PDE4B,PTGES,PTGS2,S100A12,SLC1A2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,WNT5A	45
Cellular Growth and Proliferation,Lymphoid Tissue Structure and Development	Proliferation of lymphatic system cells	6.77E-20	ADORA2A,CCL19,CCL20,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CFB,CLEC4D,CRLF2,CXCL10,CXCL3,CXCL8,EBI3,GCH1,HSH2D,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,ISG20,JAK3,LAG3,MDK,PTGS2,SIGLEC1,SIGLEC10,SLAMF1,SNAI1,SOCS3,STAT4,THBS1,TNFSF10,TRAF1	43
Lymphoid Tissue Structure and Development,Tissue Morphology	Quantity of lymphatic system cells	6.83E-20	ADORA2A,AIM2,CALHM6,CCL19,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CLEC4D,CLEC4E,CRLF2,CXCL10,CXCL13,DDX58,EBI3,HESX1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,ITGB8,JAK3,LAG3,MDK,MYO1G,PAX5,PTGIR,SERPINB2,SIGLEC1,SIGLEC10,SOCS3,STAT4,THBS1,TNFSF10,TRAF1,WNT5A	44
Cell-To-Cell Signaling and Interaction,Inflammatory Response	Immune response of leukocytes	8.13E-20	ADORA2A,CCL19,CCL20,CCL4,CCR7,CD226,CD38,CD70,CD80,CXCL1,CXCL10,CXCL3,CXCL8,DDX58,HSH2D,IL12B,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,ITGB8,MYO1G,NAMPT,SIGLEC1,SOCS3,THBS1,WNT5A	29
Infectious Diseases,Organismal Injury and Abnormalities	Severe COVID-19	9.20E-20	CCL4,CCL5,CD38,CFB,CXCL10,CXCL8,IFI27,IFI44L,IFIT3,IL1B,IL27,IRF7,ISG15,MX1,MX2,PLAC8,RSAD2,S100A12,SIGLEC1,VCAN,XAF1	21
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Activation of lymphocytes	1.12E-19	ADORA2A,AIM2,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CD80,CXCL10,CXCL8,DDX58,HSH2D,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF4,JAK3,LAG3,NAMPT,NCF1,PAX5,SIGLEC1,SIGLEC10,SLAMF1,SOCS2,STAT4,THBS1,TNFSF10,TRAF1,WNT5A	34
Endocrine System Disorders,Gastrointestinal Disease,Immunological Disease,Metabolic Disease,Organismal Injury and Abnormalities	Insulin-dependent diabetes mellitus	1.18E-19	AIM2,CALHM6,CCL19,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CFB,CXCL10,CXCL13,CXCL8,GBP4,IFIT2,IFIT3,IL12B,IL1A,IL1B,IL2RA,IL7R,IRF4,IRF7,NCF1,PTGS2,SIGLEC10,SOCS2,STAT4,TNFSF10,XAF1,ZBP1	32
Dermatological Diseases and Conditions,Immunological Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	Autoimmune bullous skin disease	1.26E-19	AIM2,APOBEC3A,BCL2L14,CD80,CXCL8,ETV7,IFI27,IFI44L,IFIT1,IFIT3,IL1A,IL1B,ISG15,LAMP3,MX1,OASL,RSAD2,THBS1,TNFSF10	19
Hematological System Development and Function,Tissue Morphology	Quantity of mononuclear leukocytes	1.82E-19	ADORA2A,AIM2,CALHM6,CCL19,CCL4,CCL5,CCR7,CD38,CD70,CD80,CLEC4D,CLEC4E,CRLF2,CXCL10,CXCL13,CXCL8,DDX58,EBI3,HESX1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,ITGB8,JAK3,LAG3,MDK,MYO1G,PAX5,PTGIR,SERPINB2,SIGLEC1,SIGLEC10,SOCS3,STAT4,THBS1,TRAF1,WNT5A	43
Digestive System Development and Function,Gastrointestinal Disease,Hepatic System Development and Function,Hepatic System Disease,Inflammatory Disease,Inflammatory Response,Organ Development,Organismal Injury and Abnormalities	Inflammation of liver	2.10E-19	ADORA2A,AIM2,CCL20,CCL4,CCL5,CCL8,CCR7,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,GBP5,IFIT2,IFIT3,IL12B,IL1A,IL1B,IL2RA,IL7R,IRF7,ISG15,NAMPT,PDE4B,SOCS3,STAT4,TNFSF10	30
Infectious Diseases,Organismal Injury and Abnormalities	Infection by RNA virus	2.51E-19	ADORA2A,CCL20,CCL4,CCL5,CCL8,CCR7,CD38,CD70,CD80,CFB,CXCL1,CXCL10,CXCL2,CXCL5,CXCL8,DDX58,EHF,EPSTI1,GCH1,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,KCNJ5,MT1X,MT2A,MX1,MX2,NAMPT,PDE4B,PLAC8,PTGS2,RSAD2,S100A12,SIGLEC1,TNFSF10,VCAN,XAF1	51
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Cell movement of neutrophils	3.14E-19	ADORA2A,AIM2,CCL19,CCL23,CCL4,CCL5,CCL8,CCR7,CFB,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL1A,IL1B,IL27,IL2RA,IRF7,JAK3,MDK,NCF1,PDE4B,PTGS2,S100A12,SOCS3,TNFAIP6	29
Infectious Diseases,Organismal Injury and Abnormalities	Neonatal late-onset sepsis	3.87E-19	ADORA2A,DDX58,IFI27,IFIT2,IFIT3,IFITM1,IL15RA,IL1A,IL1B,IL7R,IRF7,ISG15,JAK3,MT2A,MX1,NAMPT,PDE4B,SOCS3,THBS1,TNFSF10,XAF1	21
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemotaxis of leukocytes	4.52E-19	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD38,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL12B,IL1A,IL1B,MDK,PDE4B,PTGES,S100A12,SLAMF1,SOCS3,THBS1,TNFAIP6,WNT5A	29
Infectious Diseases,Organismal Injury and Abnormalities	Sepsis	7.18E-19	ACOD1,ADORA2A,CXCL8,DDX58,ENPP2,IFI27,IFIT2,IFIT3,IFITM1,IL15RA,IL1A,IL1B,IL27,IL7R,IRF7,ISG15,JAK3,KCNJ5,MT2A,MX1,NAMPT,OASL,PDE4B,PTGS2,SOCS3,STAT4,THBS1,TNFSF10,XAF1	29
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Recruitment of leukocytes	7.27E-19	CCL19,CCL20,CCL23,CCL4,CCL5,CCR7,CLEC4E,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,FPR2,IDO1,IL15RA,IL1A,IL1B,IL2RA,IRF7,MCOLN2,MDK,PDE4B,SNAI1,THBS1,VCAN	28
Cell-To-Cell Signaling and Interaction,Cellular Movement	Recruitment of myeloid cells	1.04E-18	CCL19,CCL20,CCL23,CCL4,CCL5,CCR7,CLEC4E,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IDO1,IL15RA,IL1A,IL1B,IL2RA,IRF7,MCOLN2,MDK,PDE4B,SNAI1,THBS1,VCAN	26
Cell-To-Cell Signaling and Interaction,Cellular Movement	Recruitment of cells	1.25E-18	CCL19,CCL20,CCL23,CCL4,CCL5,CCR7,CLEC4E,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,FPR2,IDO1,IL15RA,IL1A,IL1B,IL2RA,IRF7,MCOLN2,MDK,PDE4B,PTGS2,SNAI1,THBS1,VCAN	29
Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology	Quantity of lymphocytes	1.64E-18	ADORA2A,AIM2,CALHM6,CCL19,CCL4,CCL5,CCR7,CD38,CD70,CD80,CLEC4D,CLEC4E,CRLF2,CXCL10,CXCL13,DDX58,EBI3,HESX1,IL12B,IL15RA,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,ITGB8,JAK3,LAG3,MDK,MYO1G,PAX5,PTGIR,SERPINB2,SIGLEC1,SIGLEC10,SOCS3,STAT4,THBS1,TRAF1,WNT5A	41
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Lymphoid Tissue Structure and Development	Proliferation of mononuclear leukocytes	2.95E-18	ADORA2A,CCL19,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CFB,CLEC4D,CRLF2,CXCL2,CXCL8,EBI3,GCH1,HSH2D,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,ISG20,JAK3,LAG3,MDK,PTGS2,SIGLEC1,SIGLEC10,SLAMF1,SOCS3,STAT4,THBS1,TNFSF10,TRAF1	40
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Tissue Development	Differentiation of mononuclear leukocytes	2.98E-18	CCL19,CCL23,CCL5,CCR7,CD226,CD38,CD70,CD80,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL5,CXCL8,DDX58,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ITGB8,JAK3,MDK,PAX5,PTGS2,RSAD2,SIGLEC10,SLAMF1,SNAI1,SOCS2,SOCS3,STAT4,TNFSF10,WNT5A	39
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Lymphoid Tissue Structure and Development	Cell proliferation of T lymphocytes	3.38E-18	ADORA2A,CCL19,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CLEC4D,CRLF2,CXCL8,EBI3,GCH1,HSH2D,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ISG20,JAK3,LAG3,MDK,PTGS2,SIGLEC1,SLAMF1,SOCS3,STAT4,THBS1,TNFSF10,TRAF1	36
Dermatological Diseases and Conditions,Immunological Disease,Organismal Injury and Abnormalities	Pemphigus	3.68E-18	AIM2,APOBEC3A,BCL2L14,CD80,CXCL8,ETV7,IFI27,IFI44L,IFIT1,IFIT3,ISG15,LAMP3,MX1,OASL,PTGS2,RSAD2,THBS1,TNFSF10	18
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Lymphoid Tissue Structure and Development	Proliferation of immune cells	3.82E-18	ADORA2A,CCL19,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CFB,CLEC4D,CRLF2,CXCL2,CXCL3,CXCL8,EBI3,GCH1,HSH2D,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,ISG20,JAK3,LAG3,MDK,PTGS2,SIGLEC1,SIGLEC10,SLAMF1,SOCS3,STAT4,THBS1,TNFSF10,TRAF1	41
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemotaxis of phagocytes	4.52E-18	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD38,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL12B,IL1A,IL1B,MDK,PDE4B,PTGES,S100A12,SLAMF1,THBS1,TNFAIP6	26
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cell movement of antigen presenting cells	4.93E-18	ADAM19,ADORA2A,AIM2,C1QTNF1,CCL19,CCL20,CCL4,CCL5,CCR7,CD38,CD80,CXCL1,CXCL10,CXCL13,CXCL3,CXCL8,FPR2,IL12B,IL15RA,IL1A,IL1B,IRF7,MDK,PDPN,PTGES,PTGS2,SLAMF1,THBS1,VCAN,WNT5A	30
Digestive System Development and Function,Gastrointestinal Disease,Hepatic System Development and Function,Hepatic System Disease,Inflammatory Disease,Inflammatory Response,Organ Development,Organismal Injury and Abnormalities,Psychological Disorders	Alcoholic hepatitis	5.37E-18	ADORA2A,CXCL1,CXCL10,CXCL2,CXCL5,CXCL8,IFIT2,IFIT3,IL1A,IL1B,IRF7,ISG15,PDE4B	13
Inflammatory Response	Immune response of cells	6.57E-18	ADORA2A,CCL19,CCL20,CCL4,CCR7,CD226,CD38,CD70,CD80,CXCL1,CXCL10,CXCL3,CXCL8,DDX58,FPR2,HSH2D,IL12B,IL15RA,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ITGB8,MYO1G,NAMPT,NCF1,S100A12,SIGLEC1,SIGLEC10,SOCS3,THBS1,TNFSF10,WNT5A	36
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Activation of phagocytes	7.30E-18	CCL20,CCL4,CCL5,CCL8,CCR7,CD226,CD80,CLEC4D,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL3,CXCL5,CXCL8,DDX58,FPR2,IDO1,IL1A,IL1B,IL27,NAMPT,PTGES,PTGS2,S100A12,STAT4,THBS1,TNFSF10,WNT5A	29
Immunological Disease,Organismal Injury and Abnormalities	Active stage immunological disorder	7.61E-18	CD80,IFI44L,IFIT1,IFIT3,IL12B,IL1A,IL1B,IRF7,ISG15,JAK3,MT1H,MT1X,MX1,MX2,PDE4B,PTGS2,RSAD2,SOCS3	18
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Migration of phagocytes	7.93E-18	ADORA2A,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD38,CD80,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL12B,IL1B,MDK,PDE4B,PDPN,PTGS2,SOCS3,VCAN,WNT5A	26
Cellular Function and Maintenance	Homeostasis of leukocytes	1.06E-17	CCL19,CCL5,CCR7,CD226,CD38,CD70,CD80,CLEC4E,CXCL1,CXCL10,CXCL5,DDX58,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ITGB8,JAK3,LAG3,MDK,PAX5,PDE4B,PTGS2,RSAD2,SLAMF1,SOCS2,SOCS3,STAT4,TNFSF10,WNT5A	35
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Lymphoid Tissue Structure and Development	Proliferation of lymphocytes	1.18E-17	ADORA2A,CCL19,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CFB,CLEC4D,CRLF2,CXCL8,EBI3,GCH1,HSH2D,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,ISG20,JAK3,LAG3,MDK,PTGS2,SIGLEC1,SIGLEC10,SLAMF1,SOCS3,STAT4,THBS1,TNFSF10,TRAF1	39
Gastrointestinal Disease,Hepatic System Disease,Organismal Injury and Abnormalities,Psychological Disorders	Alcoholic liver disease	1.55E-17	ADORA2A,CXCL1,CXCL10,CXCL2,CXCL5,CXCL8,CYP2E1,IFIT2,IFIT3,IL1A,IL1B,IRF7,ISG15,PDE4B	14
Gastrointestinal Disease,Organismal Injury and Abnormalities	Damage of digestive system	1.56E-17	ADORA2A,CCL4,CCL5,CD80,CFB,CXCL1,CXCL10,CXCL3,CYP2E1,EBI3,FPR2,GBP5,IL12B,IL15RA,IL1A,IL1B,IL27,IL7R,NCF1,PTGS2,STAT4,TNFAIP6,TNFSF10,TRAF1	24
Tissue Morphology	Quantity of cells	1.68E-17	ADORA2A,AIM2,CALHM6,CCL19,CCL20,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CEMIP,CLEC4D,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL8,DDX58,EBI3,ETV7,FPR2,HESX1,HPN,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,ITGB8,JAK3,LAG3,MDK,MT2A,MYO1G,NKX3-1,PAX5,PDE4B,PLAC8,PLXNA4,PTGES,PTGIR,PTGS2,SERPINB2,SIGLEC1,SIGLEC10,SNAI1,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,UNC13A,VCAN,WNT5A	64
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Tissue Development	Hematopoiesis of mononuclear leukocytes	1.81E-17	CCL19,CCL23,CCL5,CCR7,CD226,CD38,CD70,CD80,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL5,DDX58,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ITGB8,JAK3,MDK,PAX5,PTGS2,RSAD2,SIGLEC10,SLAMF1,SNAI1,SOCS2,SOCS3,STAT4,TNFSF10,WNT5A	38
Cellular Function and Maintenance	Cellular homeostasis	2.40E-17	ADORA2A,ANGPTL4,C1QTNF1,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CD70,CD80,CLEC4E,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,FPR2,HELZ2,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ITGB8,JAK3,KCNJ5,LAG3,LAMP3,MAP1LC3A,MDK,MT2A,NAMPT,NCF1,PAX5,PDE4B,PLAC8,PTGES,PTGS2,RSAD2,SLAMF1,SLC8A3,SNAI1,SOCS2,SOCS3,STAT4,TNFSF10,WNT5A	60
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Recruitment of phagocytes	2.55E-17	CCL19,CCL20,CCL23,CCL4,CCL5,CCR7,CLEC4E,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IDO1,IL1A,IL1B,IL2RA,MCOLN2,MDK,PDE4B,SNAI1,THBS1,VCAN	24
Cell Death and Survival,Organismal Injury and Abnormalities	Cell death of immune cells	2.85E-17	ADORA2A,AIM2,CCL19,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CXCL1,CXCL10,CXCL2,CXCL8,HSH2D,IDO1,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,JAK3,LAG3,MX1,NAMPT,PAX5,SERPINB2,STAT4,THBS1,TNFSF10,TRAF1,WNT5A,ZBP1	36
Cell-To-Cell Signaling and Interaction,Cellular Movement,Immune Cell Trafficking	Attraction of phagocytes	3.57E-17	CCL19,CCL20,CCL4,CCL5,CXCL1,CXCL10,CXCL3,CXCL5,CXCL8,FPR2,IL12B,IL1B,VCAN	13
Cellular Function and Maintenance	Lymphocyte homeostasis	3.78E-17	CCL19,CCL5,CCR7,CD226,CD38,CD70,CD80,CLEC4E,CXCL1,CXCL10,CXCL5,DDX58,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ITGB8,JAK3,LAG3,MDK,PAX5,PTGS2,RSAD2,SLAMF1,SOCS2,SOCS3,STAT4,TNFSF10,WNT5A	34
Cell-To-Cell Signaling and Interaction	Response of lymphatic system cells	3.95E-17	ADORA2A,CCL19,CCR7,CD226,CD38,CD70,CD80,CXCL8,EBI3,IL12B,IL1B,IL27,IL2RA,IL7R,ITGB8,LAG3,NAMPT,NCF1,OASL,SIGLEC10,SOCS3,STAT4	22
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Tissue Development	Leukopoiesis	4.08E-17	CCL19,CCL23,CCL5,CCR7,CD226,CD38,CD70,CD80,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL3,CXCL5,CXCL8,DDX58,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ITGB8,JAK3,MDK,PAX5,PLAC8,PTGS2,RSAD2,SIGLEC10,SLAMF1,SNAI1,SOCS2,SOCS3,STAT4,TNFSF10,WNT5A	41
Dermatological Diseases and Conditions,Immunological Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	Pemphigus foliaceus	5.33E-17	AIM2,APOBEC3A,BCL2L14,ETV7,IFI27,IFI44L,IFIT1,IFIT3,ISG15,LAMP3,MX1,OASL,RSAD2,TNFSF10	14
Cell Death and Survival,Organismal Injury and Abnormalities	Apoptosis of leukocytes	6.10E-17	ADORA2A,CCL19,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CXCL1,CXCL2,CXCL8,HSH2D,IDO1,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ISG15,JAK3,NAMPT,PAX5,THBS1,TNFSF10,TRAF1,WNT5A,ZBP1	30
Cell-mediated Immune Response,Cellular Function and Maintenance,Hematological System Development and Function	T cell homeostasis	6.81E-17	CCL19,CCL5,CCR7,CD226,CD38,CD70,CD80,CLEC4E,CXCL1,CXCL10,CXCL5,DDX58,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ITGB8,JAK3,LAG3,MDK,PAX5,PTGS2,RSAD2,SOCS2,SOCS3,STAT4,TNFSF10,WNT5A	33
Cell-To-Cell Signaling and Interaction,Cellular Movement,Immune Cell Trafficking	Attraction of leukocytes	7.85E-17	CCL19,CCL20,CCL4,CCL5,CXCL1,CXCL10,CXCL13,CXCL3,CXCL5,CXCL8,FPR2,IL12B,IL1B,VCAN	14
Hematological System Development and Function,Inflammatory Response,Tissue Morphology	Quantity of phagocytes	1.21E-16	ADORA2A,CCL19,CCL20,CCR7,CLEC4D,CLEC4E,CRLF2,CXCL10,CXCL13,CXCL2,CXCL8,FPR2,IDO1,IL12B,IL15RA,IL1A,IL1B,IL2RA,IL7R,IRF4,JAK3,MDK,PDE4B,PLAC8,PTGIR,SERPINB2,SOCS3,STAT4,THBS1,TNFSF10,WNT5A	31
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Cellular infiltration by phagocytes	1.25E-16	ADAM19,ADORA2A,AIM2,C1QTNF1,CCL19,CCL4,CFB,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF7,JAK3,MDK,NCF1,PTGES,PTGS2,SOCS3,WNT5A	26
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemotaxis of neutrophils	1.25E-16	ADORA2A,CCL19,CCL23,CCL4,CCL5,CCL8,CCR7,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL1B,MDK,PDE4B,S100A12,TNFAIP6	19
Cellular Development,Cellular Growth and Proliferation,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development	Lymphopoiesis	1.33E-16	CCL19,CCL5,CCR7,CD226,CD38,CD70,CD80,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL5,DDX58,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ITGB8,JAK3,MDK,PAX5,PTGS2,RSAD2,SIGLEC10,SLAMF1,SNAI1,SOCS2,SOCS3,STAT4,TNFSF10,WNT5A	36
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Homing of mononuclear leukocytes	1.38E-16	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CXCL10,CXCL13,CXCL3,CXCL8,ENPP2,FPR2,IL12B,IL1B,JAK3,S100A12,SOCS3,THBS1,WNT5A	21
Cellular Movement	Homing of cells	1.68E-16	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD38,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,ENPP2,FPR2,IL12B,IL1A,IL1B,JAK3,MDK,PDE4B,PLXNA4,PTGES,PTGS2,S100A12,SLAMF1,SOCS3,THBS1,TNFAIP6,WNT5A	33
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function	Response of lymphocytes	1.84E-16	ADORA2A,CCL19,CCR7,CD226,CD38,CD70,CD80,CXCL8,EBI3,IL12B,IL1B,IL27,IL2RA,IL7R,ITGB8,LAG3,NAMPT,OASL,SIGLEC10,SOCS3,STAT4	21
Cellular Movement	Chemotaxis	2.66E-16	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD38,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,ENPP2,FPR2,IL12B,IL1A,IL1B,MDK,PDE4B,PLXNA4,PTGES,PTGS2,S100A12,SLAMF1,SOCS3,THBS1,TNFAIP6,WNT5A	32
Cellular Movement	Chemotaxis of myeloid cells	2.82E-16	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL12B,IL1B,MDK,PDE4B,PTGES,S100A12,SLAMF1,THBS1,TNFAIP6	24
Cell Death and Survival	Apoptosis	3.02E-16	ADORA2A,AIM2,ANGPTL4,APOBEC3A,BCL2L14,C1QTNF1,CCL19,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CEMIP,CFB,CLEC4E,CXCL1,CXCL10,CXCL2,CXCL8,CYP2E1,DDX58,EHF,ENPP2,EREG,FSIP1,G0S2,GBP5,HPN,HSH2D,IDO1,IFI27,IFIT2,IFIT3,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,JAK3,LAG3,MAP1LC3A,MDK,MT1F,MT2A,MX1,NAMPT,NCF1,PAX5,PDE4B,PDPN,PLAC8,PLXNA4,PRAME,PTGES,PTGS2,SLAMF1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFSF10,TRAF1,VCAN,WNT5A,XAF1,ZBP1	74
Gastrointestinal Disease,Immunological Disease,Ophthalmic Disease,Organismal Injury and Abnormalities	SjÃ¶gren syndrome	3.08E-16	CCL19,CCL20,CCL4,CCL5,CCR7,CXCL10,CXCL13,CXCL3,IFIT3,IFITM1,IL12B,IL1A,NCF1,SOCS3,STAT4,TNFSF10	16
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Migration of antigen presenting cells	3.27E-16	CCL19,CCL20,CCL4,CCL5,CCR7,CD38,CD80,CXCL1,CXCL10,CXCL13,CXCL3,CXCL8,FPR2,IL12B,IL1B,MDK,PDPN,PTGS2,VCAN,WNT5A	20
Cell Morphology	Polarization of blood cells	6.41E-16	ADORA2A,CCL19,CCL5,CCR7,CXCL10,EBI3,ENPP2,IL12B,IL1A,IL1B,IL27,IRF4,NAMPT,SLAMF1,SOCS3,STAT4,WNT5A,ZBP1	18
Cell-mediated Immune Response,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Lymphoid Tissue Structure and Development	Homing of T lymphocytes	7.12E-16	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CXCL10,CXCL13,CXCL8,IL12B,JAK3,SOCS3,THBS1,WNT5A	16
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Lymphoid Tissue Structure and Development	Homing of lymphocytes	7.67E-16	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CXCL10,CXCL13,CXCL3,CXCL8,ENPP2,IL12B,JAK3,SOCS3,THBS1,WNT5A	18
Cell-mediated Immune Response,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response,Lymphoid Tissue Structure and Development	Chemotaxis of T lymphocytes	7.71E-16	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CXCL10,CXCL13,CXCL8,IL12B,SOCS3,THBS1,WNT5A	15
Organismal Injury and Abnormalities	Non-malignant disorder	1.21E-15	CA12,CCL19,CCL20,CCL23,CCL4,CCL4L1/CCL4L2,CCL5,CCR7,CD80,CEMIP,CFB,CRLF2,CXCL10,CXCL13,CXCL3,CXCL5,CXCL8,FPR2,G0S2,HAPLN3,IFI44L,IFIT1,IFIT3,IFITM1,IL12B,IL1A,IL1B,IL2RA,IL7R,IRF4,ISG20,ITGB8,JAK3,KCNJ5,MN1,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,NAMPT,NCF1,NKG7,PAX5,PDE4B,PLAC8,PTGES,PTGS2,SERPINB2,SNAI1,SOCS3,STAT4,THBS1,TNFSF10,TRAF1,UNC13A,VCAN,XAF1	59
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemotaxis of mononuclear leukocytes	1.87E-15	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CXCL10,CXCL13,CXCL3,CXCL8,FPR2,IL12B,IL1B,S100A12,SOCS3,THBS1,WNT5A	19
Cancer,Organismal Injury and Abnormalities	Cancer of cells	2.02E-15	ABTB2,ACOD1,ADAM19,ADORA2A,AIM2,ANGPTL4,ANKRD33B,APOBEC3A,C1QTNF1,CALHM6,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EHF,ENPP2,EPSTI1,EREG,FPR2,GCH1,HAPLN3,HERC5,HSH2D,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL15RA,IL1A,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,LAG3,MAP1LC3A,MN1,MT1E,MT1G,MT1H,MX1,MYO1G,NAMPT,OASL,PANX2,PAX5,PDE4B,PDPN,PLAC8,PLXNA4,PRAME,PTGES,PTGIR,PTGS2,RSAD2,SIGLEC10,SLAMF1,SLC1A2,SLC2A6,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,UNC13A,VCAN,WFDC21P,WNT5A,XAF1	103
Inflammatory Response,Organismal Injury and Abnormalities,Respiratory Disease	Inflammation of respiratory system component	2.55E-15	ADORA2A,AIM2,CCL5,CCR7,CD70,CLEC4D,CRLF2,CXCL1,CXCL10,CXCL2,CXCL3,CXCL8,EBI3,FPR2,GCH1,IL12B,IL15RA,IL1B,IL27,IL2RA,JAK3,LAG3,NCF1,PDE4B,PDPN,PTGES,PTGS2,SOCS2,SOCS3,THBS1,TNFAIP6,WNT5A	32
Organismal Injury and Abnormalities	Fibrosis	2.65E-15	ADAM19,ADGRE1,ADORA2A,AIM2,CCL4,CCL5,CCL8,CCR7,CD38,CD80,CLEC4E,CRLF2,CXCL13,CXCL2,CXCL8,EBI3,ENPP2,GBP4,GBP5,IDO1,IFI27,IL12B,IL1A,IL1B,IL2RA,IL7R,IRF4,MDK,NAMPT,NCF1,PLAC8,PTGIR,PTGS2,S100A12,SLC2A6,SNAI1,SOCS3,STAT4,THBS1,TNFSF10,WNT5A	41
Immunological Disease,Organismal Injury and Abnormalities	Hypersensitive reaction	2.76E-15	CCL20,CCL23,CCL4,CCL5,CCR7,CLEC4D,CLEC4E,CXCL10,CXCL8,FPR2,IDO1,IFI27,IFITM1,IL12B,IL1A,IL1B,IL27,IL2RA,JAK3,MX1,NCF1,PDE4B,PTGES,PTGIR,PTGS2,SOCS2,SOCS3,TNFSF10	28
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Infiltration by neutrophils	3.14E-15	ADORA2A,AIM2,CCL4,CFB,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL1A,IL1B,IL27,IL2RA,IRF7,JAK3,MDK,NCF1,PTGS2,SOCS3	20
Cellular Function and Maintenance	Function of leukocytes	3.33E-15	ADGRE1,ADORA2A,AIM2,CCL5,CCR7,CD70,CD80,CLEC4E,CXCL10,CXCL8,DDX58,EBI3,FPR2,HSH2D,IDO1,IL12B,IL15RA,IL1B,IL27,IL2RA,IRF7,JAK3,LAG3,MYO1G,PTGS2,SLAMF1,STAT4,TNFSF10	28
Cell Death and Survival,Organismal Injury and Abnormalities	Necrosis	3.62E-15	ADORA2A,AIM2,ANGPTL4,APOBEC3A,BCL2L14,C1QTNF1,CCL19,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CEMIP,CFB,CXCL1,CXCL10,CXCL2,CXCL3,CXCL8,CYP2E1,DDX58,EHF,ENPP2,EREG,FSIP1,G0S2,GBP5,GCH1,HPN,HSH2D,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,JAK3,LAG3,MAP1LC3A,MCOLN2,MDK,MT1F,MT1X,MT2A,MX1,NAMPT,NCF1,PAX5,PDE4B,PLAC8,PLXNA4,PRAME,PTGES,PTGS2,SERPINB2,SLC1A2,SLC8A3,SNAI1,SOCS3,STAT4,THBS1,TNFSF10,TRAF1,VCAN,WNT5A,XAF1,ZBP1	74
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cellular infiltration by mononuclear leukocytes	3.67E-15	ADORA2A,AIM2,CCL19,CCL4,CCL5,CCR7,CRLF2,CXCL10,CXCL8,IL12B,IL15RA,IL1A,IL1B,IL2RA,IRF7,JAK3,LAG3,MDK,PTGES,PTGS2,TNFSF10	21
Dermatological Diseases and Conditions,Organismal Injury and Abnormalities	Chronic skin disorder	4.94E-15	CCL20,CCL5,CXCL1,CXCL10,CXCL5,CXCL8,CYP2E1,EREG,IFIT1,IFITM1,IL12B,IL1A,IL2RA,IRF7,JAK3,LAD1,MT1X,MX1,PDE4B,S100A12,WNT5A	21
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemoattraction of leukocytes	5.15E-15	CCL19,CCL20,CCL4,CCL5,CXCL1,CXCL10,CXCL13,CXCL3,CXCL5,CXCL8,FPR2,IL12B	12
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function	Activation of myeloid cells	5.34E-15	CCL23,CCL4,CCL5,CCL8,CD226,CD80,CLEC4E,CRLF2,CXCL1,CXCL10,CXCL3,CXCL5,CXCL8,FPR2,IL1A,IL1B,IL27,NAMPT,PTGES,PTGS2,S100A12,STAT4,THBS1,TNFSF10,WNT5A	25
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response,Lymphoid Tissue Structure and Development	Chemotaxis of lymphocytes	6.17E-15	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CXCL10,CXCL13,CXCL3,CXCL8,IL12B,SOCS3,THBS1,WNT5A	16
Cell-To-Cell Signaling and Interaction,Cellular Growth and Proliferation	Stimulation of cells	6.93E-15	ADORA2A,CCL19,CCL20,CCL5,CD70,CD80,CLEC4E,CXCL10,CXCL13,CXCL3,CXCL5,CXCL8,IL12B,IL1A,IL1B,IL27,PLXNA4,PTGES,PTGS2,SLAMF1,THBS1,TNFSF10,WNT5A	23
Inflammatory Response	Innate immune response	7.28E-15	ACOD1,APOBEC3A,CCL5,CLEC4D,CLEC4E,CXCL1,CXCL10,CXCL8,DDX58,EREG,FPR2,GBP5,IFI27,IFIT2,IRF7,ISG15,MX1,NCF1,S100A12,ZBP1	20
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemoattraction of phagocytes	7.53E-15	CCL19,CCL20,CCL4,CCL5,CXCL1,CXCL10,CXCL3,CXCL5,CXCL8,FPR2,IL12B	11
Cancer,Organismal Injury and Abnormalities	Neoplasia of cells	8.05E-15	ABTB2,ACOD1,ADAM19,ADORA2A,AIM2,ANGPTL4,ANKRD22,ANKRD33B,APOBEC3A,BCL2L14,C1QTNF1,CALHM6,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EHF,ENPP2,EPSTI1,EREG,FPR2,G0S2,GCH1,HAPLN3,HERC5,HSH2D,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,LAG3,MAP1LC3A,MN1,MT1E,MT1G,MT1H,MX1,MYO1G,NAMPT,NSUN7,OASL,PANX2,PAX5,PDE4B,PDPN,PLAC8,PLXNA4,PRAME,PTGES,PTGIR,PTGS2,RSAD2,SERPINB2,SIGLEC10,SLAMF1,SLC1A2,SLC2A6,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,UNC13A,VCAN,WFDC21P,WNT5A,XAF1	109
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Recruitment of antigen presenting cells	9.16E-15	CCL19,CCL20,CCL4,CCL5,CLEC4E,CXCL10,CXCL3,CXCL8,FPR2,IDO1,IL1B,IRF7,MCOLN2,MDK,SNAI1,THBS1	16
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Recruitment of granulocytes	9.34E-15	CCL19,CCL20,CCL4,CCL5,CCR7,CLEC4E,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL15RA,IL1A,IL1B,MDK,PDE4B,THBS1,VCAN	20
Cell Morphology	Polarization of leukocytes	9.40E-15	ADORA2A,CCL19,CCL5,CCR7,EBI3,ENPP2,IL12B,IL1A,IL1B,IL27,IRF4,NAMPT,SLAMF1,SOCS3,STAT4,WNT5A,ZBP1	17
Infectious Diseases,Organismal Injury and Abnormalities	Replication of virus	1.23E-14	CCL4,CCL5,CD38,CXCL10,CXCL3,CXCL8,CYP2E1,DDX58,EBI3,HERC5,IFI27,IFIT1,IFITM1,IL1A,IL1B,IL27,IRF7,ISG15,ISG20,MAP1LC3A,MX1,MX2,OASL,PTGS2,RSAD2,S100A12,SOCS2,SOCS3,STAT4,TNFSF10,ZBP1	31
Cell-To-Cell Signaling and Interaction,Cellular Movement	Attraction of myeloid cells	1.25E-14	CCL4,CCL5,CXCL1,CXCL10,CXCL3,CXCL5,CXCL8,FPR2,IL12B,IL1B,VCAN	11
Organismal Injury and Abnormalities,Respiratory Disease	Chronic obstructive pulmonary disease	1.27E-14	ADAM19,ADORA2A,CA12,CCL5,CXCL3,CXCL8,IL1B,IL2RA,IL7R,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,PDE4B,PTGIR,PTGS2,WNT5A	20
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Cell movement of dendritic cells	1.43E-14	CCL19,CCL20,CCL4,CCL5,CCR7,CD38,CD80,CXCL10,CXCL13,CXCL8,FPR2,IL12B,IL1A,IL1B,IRF7,MDK,PDPN,SLAMF1	18
Cell-mediated Immune Response,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development	T cell development	1.44E-14	CCL5,CCR7,CD226,CD70,CD80,CLEC4E,CXCL1,CXCL10,CXCL5,DDX58,IDO1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ITGB8,JAK3,MDK,PAX5,PTGS2,RSAD2,SOCS2,SOCS3,STAT4,TNFSF10,WNT5A	30
Hematological System Development and Function,Tissue Morphology	Quantity of granulocytes	3.17E-14	ADORA2A,CLEC4E,CRLF2,CXCL2,CXCL8,DDX58,EBI3,FPR2,IL1A,IL1B,IL2RA,IRF4,JAK3,MDK,PDE4B,PLAC8,PTGES,PTGIR,PTGS2,SERPINB2,SOCS3,STAT4,THBS1,TNFSF10	24
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking	Adhesion of immune cells	3.31E-14	ADORA2A,CCL19,CCL20,CCL4,CCL5,CCR7,CD226,CD38,CD80,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL8,FPR2,IL1A,IL1B,IL7R,JAK3,MYO1G,PTGS2,SOCS3,THBS1	24
Cell-mediated Immune Response,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Movement of CD4+ T-lymphocytes	3.63E-14	ADORA2A,CCL19,CCL20,CCL4,CCL5,CCR7,CRLF2,CXCL1,CXCL10,ENPP2,IL12B,IL15RA,IRF7,LAG3	14
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function	T cell response	3.77E-14	CCL19,CD226,CD70,CD80,CXCL8,EBI3,IL12B,IL1B,IL27,IL2RA,IL7R,ITGB8,LAG3,NAMPT,OASL,SOCS3,STAT4	17
Infectious Diseases,Organismal Injury and Abnormalities,Respiratory Disease	Infection of respiratory tract	4.13E-14	CCL20,CCL4,CCL5,CCR7,CD70,CLEC4E,CXCL10,CXCL2,CXCL3,CXCL8,DDX58,IL12B,IL1A,IL1B,IL2RA,IRF7,NCF1,PTGS2,S100A12,STAT4	20
Cell Morphology	Polarization of mononuclear leukocytes	4.13E-14	CCL19,CCR7,EBI3,ENPP2,IL12B,IL1A,IL1B,IL27,IRF4,NAMPT,SLAMF1,SOCS3,STAT4	13
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Recruitment of mononuclear leukocytes	4.40E-14	CCL19,CCL20,CCL23,CCL4,CCL5,CCR7,CLEC4E,CXCL10,CXCL13,CXCL3,CXCL8,DDX58,FPR2,IL15RA,IL1B,MCOLN2	16
Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Respiratory Disease	Inflammation of lung	4.70E-14	ADORA2A,AIM2,CCR7,CD70,CLEC4D,CRLF2,CXCL1,CXCL2,CXCL3,FPR2,GCH1,IL12B,IL15RA,IL1B,IL27,IL2RA,JAK3,LAG3,NCF1,PTGES,PTGS2,SOCS2,THBS1,TNFAIP6,WNT5A	25
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Cell movement of macrophages	5.14E-14	ADAM19,ADORA2A,AIM2,C1QTNF1,CCL19,CCL4,CCL5,CXCL1,CXCL10,CXCL3,CXCL8,FPR2,IL12B,IL15RA,IL1A,IL1B,MDK,PTGES,PTGS2,SLAMF1,THBS1,VCAN,WNT5A	23
Cell Morphology	Polarization of cells	5.58E-14	ADORA2A,CCL19,CCL5,CCR7,CXCL10,CXCL8,EBI3,ENPP2,IL12B,IL1A,IL1B,IL27,IRF4,NAMPT,SLAMF1,SOCS3,STAT4,WNT5A,ZBP1	19
Cell Death and Survival,Organismal Injury and Abnormalities	Cell death of mononuclear leukocytes	5.92E-14	ADORA2A,CCL19,CCL4,CCL5,CD226,CD38,CD70,CD80,CXCL10,HSH2D,IDO1,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,JAK3,LAG3,PAX5,THBS1,TNFSF10,TRAF1,WNT5A	25
Cellular Function and Maintenance	Function of lymphatic system cells	6.94E-14	ADGRE1,ADORA2A,CCL5,CCR7,CD70,CD80,CXCL10,EBI3,FPR2,HSH2D,IL12B,IL15RA,IL1B,IL27,IL2RA,IRF7,JAK3,LAG3,MYO1G,SLAMF1,STAT4,TNFSF10	22
Inflammatory Disease,Organismal Injury and Abnormalities	Severe inflammatory disorder	8.72E-14	ADORA2A,CCL5,CCR7,CD80,CLEC4E,CXCL10,CXCL8,IFIT2,IFIT3,IL12B,IL1A,IL1B,IRF7,ISG15,JAK3,NCF1,PDE4B,PDPN,PTGS2,S100A12,STAT4	21
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Recruitment of neutrophils	8.77E-14	CCL19,CCL20,CCL4,CCL5,CCR7,CLEC4E,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL1A,IL1B,MDK,PDE4B,VCAN	18
Cancer,Hematological Disease,Organismal Injury and Abnormalities	Hematopoietic neoplasm	9.60E-14	ADAM19,ADORA2A,AIM2,ANGPTL4,ANKRD22,APOBEC3A,APOL3,BCL2L14,C1QTNF1,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL8,CYP2E1,DDX58,EBI3,ENPP2,EPSTI1,FPR2,HAPLN3,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL1A,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,LAG3,MN1,MX1,MYO1G,NAMPT,NKX3-1,NSUN7,OASL,PAX5,PDE4B,PLAC8,PLXNA4,PTGS2,RSAD2,SERPINB2,SIGLEC10,SLC1A2,SLC8A3,SNAI1,SOCS2,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,UNC13A,VCAN,WNT5A,XAF1,ZBP1	83
Cell Morphology	Polarization of T lymphocytes	1.30E-13	CCL19,CCR7,EBI3,ENPP2,IL12B,IL1A,IL1B,IL27,IRF4,SLAMF1,SOCS3,STAT4	12
Dermatological Diseases and Conditions,Organismal Injury and Abnormalities	Exanthem of skin	1.42E-13	CCL20,CCL5,CXCL1,CXCL10,CXCL5,CXCL8,CYP2E1,IL12B,IL1A,IL1B,IL2RA,JAK3,MT1X,PDE4B,S100A12,WNT5A	16
Cell-To-Cell Signaling and Interaction,Cellular Movement	Chemoattraction	1.56E-13	CCL19,CCL20,CCL4,CCL5,CXCL1,CXCL10,CXCL13,CXCL3,CXCL5,CXCL8,FPR2,IL12B,IL1B	13
Connective Tissue Disorders,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Polyarthritis	1.66E-13	CCL20,CCL4,CCL5,CD70,CD80,FPR2,IL12B,IL1A,IL1B,JAK3,NAMPT,PTGIR,PTGS2,S100A12,SLC1A2,STAT4,THBS1	17
Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology	Quantity of regulatory T lymphocytes	1.67E-13	ADORA2A,CCL19,CCL4,CCL5,CCR7,CD38,CD70,CD80,EBI3,IL12B,IL2RA,IL7R,ITGB8,MDK,THBS1,WNT5A	16
Cell Death and Survival,Organismal Injury and Abnormalities	Cell death of T lymphocytes	1.73E-13	ADORA2A,CCL19,CCL4,CCL5,CD226,CD38,CD70,CXCL10,IDO1,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,JAK3,LAG3,THBS1,TNFSF10,TRAF1,WNT5A	22
Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology	Quantity of T lymphocytes	1.77E-13	ADORA2A,AIM2,CCL19,CCL4,CCL5,CCR7,CD38,CD70,CD80,CRLF2,CXCL10,DDX58,EBI3,HESX1,IL12B,IL15RA,IL27,IL2RA,IL7R,IRF4,ITGB8,JAK3,LAG3,MDK,PTGIR,SIGLEC1,SIGLEC10,SOCS3,THBS1,WNT5A	30
Gastrointestinal Disease,Organismal Injury and Abnormalities	Benign oral disorder	1.79E-13	CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCR7,CXCL10,CXCL13,CXCL3,CXCL8,G0S2,IFIT3,IFITM1,IL12B,IL1A,IL1B,IL7R,ITGB8,MN1,NAMPT,NCF1,NKG7,PDE4B,PLAC8,PTGS2,SNAI1,SOCS3,STAT4,TNFSF10	29
Metabolic Disease,Organismal Injury and Abnormalities	Glucose metabolism disorder	1.82E-13	ADORA2A,AIM2,ANGPTL4,CA12,CALHM6,CCL19,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CFB,CXCL1,CXCL10,CXCL13,CXCL8,CYP2E1,EBI3,ENPP2,G0S2,GBP4,GFPT2,HPN,IFIT1,IFIT2,IFIT3,IL12B,IL15RA,IL1A,IL1B,IL2RA,IL7R,IRF4,IRF7,KCNJ5,LINC01619,MT1G,MT2A,NCF1,PDE4B,PTGIR,PTGS2,RSAD2,SIGLEC10,SOCS2,SOCS3,STAT4,THBS1,TNFSF10,XAF1,ZBP1	53
Cancer,Organismal Injury and Abnormalities	Invasive tumor	2.01E-13	ADORA2A,ANGPTL4,CALHM6,CCL19,CCL5,CCL8,CCR7,CD226,CD80,CEMIP,CLEC4D,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,EBI3,ENPP2,EPSTI1,G0S2,GCH1,IDO1,IFITM1,IL15RA,IL1A,IL1B,IL2RA,IRF4,IRF7,ISG15,JAK3,LAG3,MT1E,MX1,NKX3-1,PRAME,PTGS2,SERPINB2,SNAI1,SOCS3,THBS1,TNFAIP6,UNC13A,VCAN,WFDC21P,WNT5A,ZBP1	49
Cellular Function and Maintenance,Hematological System Development and Function	Function of lymphocytes	2.09E-13	ADGRE1,ADORA2A,CCL5,CCR7,CD70,CD80,CXCL10,EBI3,HSH2D,IL12B,IL15RA,IL1B,IL27,IL2RA,IRF7,JAK3,LAG3,MYO1G,SLAMF1,STAT4,TNFSF10	21
Cell Death and Survival,Organismal Injury and Abnormalities	Cell death of lymphocytes	2.10E-13	ADORA2A,CCL19,CCL4,CCL5,CD226,CD38,CD70,CD80,CXCL10,HSH2D,IDO1,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,JAK3,LAG3,THBS1,TNFSF10,TRAF1,WNT5A	24
Inflammatory Response	Cell-mediated response	2.29E-13	CCL5,CCR7,CD226,CD80,CXCL10,CXCL8,EBI3,IDO1,IL12B,IL15RA,IL1B,IL7R,ITGB8,LAG3,NAMPT,NCF1,SOCS2,STAT4	18
Organismal Survival	Survival of organism	2.36E-13	ADORA2A,AIM2,C1QTNF1,CD80,CFB,CLEC4D,CXCL10,CXCL2,CXCL3,DDX58,EREG,IDO1,IL12B,IL1A,IL1B,IL27,IL2RA,IL7R,IRF7,LAG3,MDK,MX1,NAMPT,NCF1,NKX3-1,PTGES,PTGS2,RSAD2,SLC1A2,SNAI1,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,WNT5A	36
Organismal Injury and Abnormalities,Psychological Disorders	Alcohol use disorder	2.43E-13	ADORA2A,CA12,CXCL1,CXCL10,CXCL2,CXCL5,CXCL8,CYP2E1,IFIT2,IFIT3,IL1A,IL1B,IRF7,ISG15,PDE4B	15
Cellular Growth and Proliferation	Expansion of cells	2.45E-13	ADORA2A,CCL19,CCR7,CD70,CD80,EREG,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,JAK3,LAG3,MDK,PAX5,PTGS2,SIGLEC10,SLAMF1,STAT4,TNFAIP6,WNT5A	22
Dermatological Diseases and Conditions,Organismal Injury and Abnormalities	Plaque psoriasis	2.65E-13	CCL20,CCL5,CXCL1,CXCL10,CXCL5,CXCL8,CYP2E1,IL12B,IL1A,IL2RA,JAK3,MT1X,PDE4B,S100A12,WNT5A	15
Cell Death and Survival,Organismal Injury and Abnormalities	Apoptosis of mononuclear leukocytes	3.26E-13	ADORA2A,CCL19,CCL4,CCL5,CD226,CD38,CD70,CD80,HSH2D,IDO1,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,JAK3,PAX5,THBS1,TNFSF10,TRAF1,WNT5A	23
Endocrine System Disorders,Gastrointestinal Disease,Metabolic Disease,Organismal Injury and Abnormalities	Diabetes mellitus	3.38E-13	ADORA2A,AIM2,CA12,CALHM6,CCL19,CCL4,CCL5,CCR7,CD226,CD38,CD70,CD80,CFB,CXCL10,CXCL13,CXCL8,CYP2E1,G0S2,GBP4,GFPT2,HPN,IFIT1,IFIT2,IFIT3,IL12B,IL15RA,IL1A,IL1B,IL2RA,IL7R,IRF4,IRF7,KCNJ5,LINC01619,MT1G,MT2A,NCF1,PDE4B,PTGIR,PTGS2,RSAD2,SIGLEC10,SOCS2,SOCS3,STAT4,TNFSF10,XAF1,ZBP1	48
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	Tumorigenesis of lymphocytes	4.71E-13	ADAM19,ADORA2A,AIM2,APOBEC3A,C1QTNF1,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL8,DDX58,EBI3,EPSTI1,FPR2,HAPLN3,IDO1,IFI44L,IFIT2,IFIT3,IFITM1,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,LAG3,MX1,MYO1G,NAMPT,OASL,PAX5,PDE4B,PLAC8,PLXNA4,PTGS2,RSAD2,SIGLEC10,SLC1A2,SLC8A3,SOCS2,STAT4,THBS1,TNFSF10,TRAF1,VCAN,XAF1	64
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cellular infiltration by lymphocytes	5.63E-13	ADORA2A,AIM2,CCL19,CCL5,CCR7,CRLF2,CXCL10,CXCL8,IL15RA,IL1A,IL1B,IL2RA,IRF7,LAG3,MDK,PTGES,PTGS2,TNFSF10	18
Connective Tissue Disorders,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Experimentally-induced arthritis	5.63E-13	CCL4,CD70,CFB,CXCL13,CXCL2,CXCL8,FPR2,IL12B,IL1B,MDK,NAMPT,PTGIR,PTGS2,STAT4,THBS1,TNFAIP6	16
Cancer,Organismal Injury and Abnormalities	Metastasis	5.97E-13	ADORA2A,ANGPTL4,CALHM6,CCL19,CCL5,CCL8,CCR7,CD226,CD80,CEMIP,CLEC4D,CXCL1,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,EBI3,ENPP2,EPSTI1,GCH1,IDO1,IL15RA,IL1A,IL1B,IL2RA,IRF4,IRF7,ISG15,LAG3,MX1,PRAME,PTGS2,SERPINB2,SNAI1,SOCS3,THBS1,UNC13A,VCAN,WFDC21P,WNT5A,ZBP1	42
Gastrointestinal Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	Experimental colitis	5.97E-13	ACOD1,CCL5,CEMIP,CFB,CLEC4E,CXCL10,CXCL13,CXCL3,EREG,GBP5,IDO1,IL12B,IL1A,IL1B,JAK3,SOCS3,ZBP1	17
Hematological System Development and Function,Tissue Development	Accumulation of blood cells	6.03E-13	ADORA2A,CCL5,CCR7,CD70,CD80,CXCL1,CXCL10,CXCL2,CXCL3,CXCL8,ENPP2,IL12B,IL1B,IL2RA,IRF4,MDK,NCF1,PTGS2,SOCS3,THBS1,TNFSF10	21
Cancer,Dermatological Diseases and Conditions,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	Cutaneous T-cell lymphoma	6.21E-13	CCL8,CCR7,CXCL10,CXCL13,IDO1,IFITM1,IL2RA,IRF4,IRF7,ISG15,ISG20,JAK3,MX1,OASL,RSAD2	15
Cellular Development,Hematological System Development and Function,Lymphoid Tissue Structure and Development	Maturation of leukocytes	7.52E-13	ADORA2A,CCL19,CCL20,CCL5,CD80,DDX58,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,PTGS2,SOCS2,THBS1,TNFSF10	18
Gastrointestinal Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	Dextran sodium sulfate-induced colitis	9.30E-13	ACOD1,CCL5,CEMIP,CFB,CLEC4E,CXCL10,CXCL13,CXCL3,EREG,GBP5,IDO1,IL1A,IL1B,JAK3,SOCS3,ZBP1	16
Cell Death and Survival,Organismal Injury and Abnormalities	Apoptosis of T lymphocytes	1.06E-12	ADORA2A,CCL19,CCL4,CCL5,CD226,CD38,CD70,IDO1,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,JAK3,THBS1,TNFSF10,TRAF1,WNT5A	20
Infectious Diseases,Organismal Injury and Abnormalities	Tuberculosis	1.07E-12	CCL20,CCL8,CCR7,CXCL10,CXCL8,GBP5,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL2RA,IRF7,MX1,PTGS2	16
Organismal Injury and Abnormalities,Reproductive System Disease	Endometriosis	1.08E-12	CCL19,CCL23,CCL4,CEMIP,CXCL10,CXCL13,CXCL5,CXCL8,FPR2,G0S2,IL1A,IL1B,IL2RA,IL7R,ISG20,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,PTGS2,TRAF1	23
Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology	Quantity of TREG cells	1.09E-12	ADORA2A,CCL19,CCL5,CCR7,CD38,CD70,CD80,EBI3,IL12B,IL2RA,IL7R,ITGB8	12
Cell Death and Survival,Organismal Injury and Abnormalities	Apoptosis of lymphocytes	1.10E-12	ADORA2A,CCL19,CCL4,CCL5,CD226,CD38,CD70,CD80,HSH2D,IDO1,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,JAK3,THBS1,TNFSF10,TRAF1,WNT5A	22
Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response,Tissue Development	Accumulation of leukocytes	1.11E-12	ADORA2A,CCL5,CCR7,CD70,CD80,CXCL1,CXCL10,CXCL2,CXCL3,CXCL8,ENPP2,IL12B,IL1B,IL2RA,IRF4,NCF1,PTGS2,SOCS3,THBS1,TNFSF10	20
Hematological System Development and Function,Inflammatory Response,Tissue Morphology	Quantity of dendritic cells	1.28E-12	CCL19,CCL20,CCR7,CLEC4D,CLEC4E,CXCL13,FPR2,IDO1,IL15RA,IL1B,IL2RA,IL7R,IRF4,JAK3,MDK	15
Inflammatory Response,Neurological Disease,Organismal Injury and Abnormalities	Inflammation of central nervous system	1.33E-12	ADORA2A,CCL5,CCR7,CD70,CD80,CLEC4D,CLEC4E,CXCL10,EBI3,IDO1,IFIT2,IL12B,IL1B,IL27,IL2RA,IRF4,ISG15,ITGB8,LAG3,MDK,NCF1,PTGES,PTGS2,STAT4,TNFSF10	25
Cell-To-Cell Signaling and Interaction,Cellular Growth and Proliferation,Hematological System Development and Function	Stimulation of leukocytes	1.51E-12	CCL19,CCL20,CCL5,CD70,CD80,CLEC4E,CXCL10,CXCL3,CXCL5,CXCL8,IL12B,IL1B,IL27,SLAMF1,TNFSF10,WNT5A	16
Infectious Diseases,Organismal Injury and Abnormalities	Replication of RNA virus	1.69E-12	CCL4,CCL5,CD38,CXCL10,CXCL8,CYP2E1,DDX58,HERC5,IFI27,IFIT1,IFITM1,IL1A,IL1B,IL27,IRF7,ISG15,ISG20,MAP1LC3A,MX1,OASL,PTGS2,RSAD2,S100A12,SOCS2,SOCS3,STAT4,TNFSF10	27
Hematological System Development and Function,Tissue Morphology	Quantity of antigen presenting cells	1.70E-12	ADORA2A,CCL19,CCL20,CCR7,CLEC4D,CLEC4E,CXCL10,CXCL13,FPR2,IDO1,IL12B,IL15RA,IL1A,IL1B,IL2RA,IL7R,IRF4,JAK3,MDK,SOCS3,STAT4,WNT5A	22
Inflammatory Disease,Inflammatory Response,Neurological Disease,Organismal Injury and Abnormalities	Encephalitis	1.76E-12	ADORA2A,CCL5,CCR7,CD70,CD80,CLEC4D,CLEC4E,CXCL10,EBI3,IDO1,IFIT2,IL12B,IL1B,IL27,IL2RA,IRF4,ISG15,ITGB8,LAG3,MDK,NCF1,PTGES,STAT4,TNFSF10	24
Tissue Development	Accumulation of cells	1.76E-12	ADORA2A,CCL5,CCR7,CD70,CD80,CLEC4E,CXCL1,CXCL10,CXCL2,CXCL3,CXCL8,ENPP2,IL12B,IL1B,IL2RA,IRF4,MDK,NCF1,PTGS2,SOCS3,THBS1,TNFSF10	22
Immunological Disease,Inflammatory Disease,Organismal Injury and Abnormalities	Active stage systemic lupus erythematosus	1.80E-12	IFI44L,IFIT1,IFIT3,IL12B,IRF7,ISG15,MT1H,MT1X,MX1,MX2,RSAD2,SOCS3	12
Cancer,Organismal Injury and Abnormalities	Advanced malignant tumor	1.99E-12	ADORA2A,ANGPTL4,CALHM6,CCL19,CCL5,CCL8,CCR7,CD226,CD80,CEMIP,CLEC4D,CXCL1,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,EBI3,ENPP2,EPSTI1,GCH1,IDO1,IL15RA,IL1A,IL1B,IL2RA,IRF4,IRF7,ISG15,JAK3,LAG3,MX1,PRAME,PTGS2,SERPINB2,SNAI1,SOCS3,THBS1,UNC13A,VCAN,WFDC21P,WNT5A,ZBP1	43
Immunological Disease,Organismal Injury and Abnormalities	Allergy	2.30E-12	ADAM19,ADORA2A,CCL20,CCL23,CCL4,CCL5,CXCL1,CXCL8,FPR2,GCH1,IFI27,IL12B,IL1A,IL1B,IL27,IL2RA,JAK3,MX1,PDE4B,PTGIR,PTGS2,SOCS2,SOCS3,TNFSF10	24
Infectious Diseases,Organismal Injury and Abnormalities	Infection of mammalia	2.37E-12	AIM2,CCR7,CD70,CFB,CLEC4D,CLEC4E,CXCL10,DDX58,EBI3,IFIT2,IL12B,IL1B,IRF4,IRF7,ISG15,NCF1,PLAC8,SIGLEC1,SLAMF1,STAT4,TNFSF10	21
Cancer,Hematological Disease,Organismal Injury and Abnormalities	Mature lymphocytic neoplasm	2.50E-12	ADAM19,AIM2,APOBEC3A,C1QTNF1,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CXCL1,CXCL10,CXCL13,CXCL2,CXCL8,DDX58,EBI3,EPSTI1,IDO1,IFI44L,IFIT2,IFIT3,IFITM1,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,MX1,MYO1G,NAMPT,OASL,PAX5,PLXNA4,PTGS2,RSAD2,SIGLEC10,SLC8A3,SOCS2,STAT4,TNFSF10,TRAF1,VCAN	53
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Recruitment of lymphocytes	2.56E-12	CCL19,CCL20,CCL4,CCL5,CCR7,CLEC4E,CXCL10,CXCL13,CXCL3,CXCL8,DDX58,IL15RA,IL1B	13
Cell-To-Cell Signaling and Interaction	Intercellular communication	3.15E-12	ADORA2A,CCL20,CCL23,CCL4,CD70,CXCL10,CXCL5,EREG,IL1B,NAMPT,PANX2,PTGIR,TNFAIP6,TNFSF10,WNT5A	15
Organismal Injury and Abnormalities,Reproductive System Disease	Benign pelvic disease	3.38E-12	CCL19,CCL23,CCL4,CEMIP,CFB,CRLF2,CXCL10,CXCL13,CXCL5,CXCL8,FPR2,G0S2,HAPLN3,IFI44L,IFIT1,IFIT3,IL1A,IL1B,IL2RA,IL7R,IRF4,ISG20,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,PTGS2,SOCS3,TNFSF10,TRAF1,VCAN,XAF1	34
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	Lymphoma	3.67E-12	ADAM19,ADORA2A,AIM2,APOBEC3A,C1QTNF1,CCL19,CCL20,CCL5,CCL8,CCR7,CD38,CD70,CD80,CXCL10,CXCL13,CXCL8,DDX58,EBI3,FPR2,IDO1,IFI44L,IFIT2,IFIT3,IFITM1,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,LAG3,MX1,MYO1G,OASL,PAX5,PDE4B,PLAC8,PLXNA4,PTGS2,RSAD2,SIGLEC10,SLC8A3,STAT4,THBS1,TNFSF10,TRAF1	49
Gastrointestinal Disease,Hepatic System Disease,Organismal Injury and Abnormalities	Liver Damage	4.12E-12	ADORA2A,CCL4,CCL5,CXCL1,CXCL10,CYP2E1,EBI3,FPR2,GBP5,IL1A,IL1B,IL27,NCF1,PTGS2,STAT4,TNFSF10,TRAF1	17
Infectious Diseases,Organismal Injury and Abnormalities	Replication of Flaviviridae	4.12E-12	CXCL10,CYP2E1,DDX58,IFI27,IFIT1,IFITM1,ISG15,MAP1LC3A,OASL,RSAD2,SOCS2,SOCS3	12
Cancer,Hematological Disease,Organismal Injury and Abnormalities	Hematologic cancer	4.14E-12	ADAM19,ADORA2A,AIM2,ANGPTL4,ANKRD22,APOBEC3A,APOL3,BCL2L14,C1QTNF1,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL8,CYP2E1,DDX58,EBI3,ENPP2,EPSTI1,FPR2,HAPLN3,IDO1,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,LAG3,MN1,MX1,MYO1G,NAMPT,NSUN7,OASL,PAX5,PDE4B,PLAC8,PLXNA4,PTGS2,RSAD2,SERPINB2,SIGLEC10,SLC1A2,SLC8A3,SNAI1,SOCS2,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,UNC13A,VCAN,XAF1,ZBP1	79
Gastrointestinal Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	Acute colitis	4.22E-12	ACOD1,CCL5,CEMIP,CLEC4E,CXCL10,CXCL3,EREG,GBP5,IDO1,PTGS2	10
Cell-To-Cell Signaling and Interaction,Cellular Movement	Chemoattraction of myeloid cells	4.28E-12	CCL4,CCL5,CXCL1,CXCL10,CXCL3,CXCL5,CXCL8,FPR2,IL12B	9
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	T-cell non-Hodgkin lymphoma	4.45E-12	ADAM19,ADORA2A,AIM2,C1QTNF1,CCL19,CCL20,CCL8,CCR7,CD38,CXCL10,CXCL13,CXCL8,EBI3,IDO1,IFI44L,IFIT2,IFIT3,IFITM1,IL2RA,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,MX1,OASL,PAX5,PLXNA4,RSAD2,STAT4	31
Digestive System Development and Function,Gastrointestinal Disease,Hepatic System Development and Function,Hepatic System Disease,Inflammatory Disease,Inflammatory Response,Organ Development,Organismal Injury and Abnormalities	Severe hepatitis	4.79E-12	ADORA2A,CCR7,CXCL10,IFIT2,IFIT3,IRF7,ISG15,PDE4B	8
Cellular Function and Maintenance,Hematological System Development and Function	Function of T lymphocytes	5.18E-12	ADGRE1,CCL5,CCR7,CD70,CD80,CXCL10,EBI3,HSH2D,IL12B,IL27,IL2RA,IRF7,JAK3,LAG3,MYO1G,SLAMF1,STAT4,TNFSF10	18
Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Neuromuscular disease	5.26E-12	ADGRE1,ADORA2A,CA12,CCL4,CCL5,CD38,CD80,CFB,CXCL1,CXCL10,CXCL13,DDX58,ENPP2,EPSTI1,GCH1,IDO1,IFIT1,IFIT3,IL1A,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,KCNA2,LAG3,MT1E,MT1G,MT1H,MT1M,MT1X,MT2A,MX1,PDE4B,PTGS2,RSAD2,SLC1A2,VCAN,ZBP1	40
Gastrointestinal Disease,Hepatic System Disease,Organismal Injury and Abnormalities	Hepatic injury	6.56E-12	ADORA2A,CCL4,CCL5,CXCL1,CXCL10,CYP2E1,EBI3,FPR2,GBP5,IL1A,IL27,NCF1,STAT4,TRAF1	14
Cell-mediated Immune Response,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development	Differentiation of T lymphocytes	6.76E-12	CCL5,CD226,CD70,CD80,CLEC4E,CXCL1,CXCL5,DDX58,IDO1,IL12B,IL1B,IL27,IL2RA,IL7R,IRF4,ITGB8,JAK3,MDK,PTGS2,RSAD2,SOCS2,SOCS3,STAT4	23
Immunological Disease,Inflammatory Disease,Inflammatory Response,Neurological Disease,Organismal Injury and Abnormalities	Experimental autoimmune encephalomyelitis	7.50E-12	ADORA2A,CCL5,CCR7,CD80,CLEC4D,CLEC4E,CXCL10,EBI3,IDO1,IL12B,IL1B,IL27,IL2RA,IRF4,ISG15,ITGB8,LAG3,MDK,NCF1,PTGES,STAT4,TNFSF10	22
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemotaxis of antigen presenting cells	8.97E-12	CCL19,CCL20,CCL4,CCL5,CCR7,CD38,CXCL10,FPR2,IL12B,IL1A,IL1B,MDK,PTGES,SLAMF1,THBS1	15
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	Lymphocytic cancer	9.21E-12	ADAM19,ADORA2A,AIM2,APOBEC3A,APOL3,C1QTNF1,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL8,DDX58,EBI3,EPSTI1,FPR2,HAPLN3,IDO1,IFI44L,IFIT2,IFIT3,IFITM1,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,LAG3,MX1,MYO1G,NAMPT,OASL,PAX5,PDE4B,PLAC8,PLXNA4,PTGS2,RSAD2,SIGLEC10,SLC1A2,SLC8A3,SOCS2,STAT4,THBS1,TNFSF10,TRAF1,VCAN,XAF1,ZBP1	66
Cancer,Hematological Disease,Organismal Injury and Abnormalities	Malignant lymphocytic neoplasm	9.21E-12	ADAM19,ADORA2A,AIM2,APOBEC3A,APOL3,C1QTNF1,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL8,DDX58,EBI3,EPSTI1,FPR2,HAPLN3,IDO1,IFI44L,IFIT2,IFIT3,IFITM1,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,LAG3,MX1,MYO1G,NAMPT,OASL,PAX5,PDE4B,PLAC8,PLXNA4,PTGS2,RSAD2,SIGLEC10,SLC1A2,SLC8A3,SOCS2,STAT4,THBS1,TNFSF10,TRAF1,VCAN,XAF1,ZBP1	66
Organismal Injury and Abnormalities,Renal and Urological Disease	Renal impairment	9.45E-12	ADORA2A,CA12,CD80,CFB,CLEC4E,CXCL8,IDO1,IL1A,IL1B,IL2RA,IRF4,MDK,PDE4B,PTGIR,PTGS2,SLC2A6,SOCS2,THBS1,WNT5A	19
Cell-mediated Immune Response,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Infiltration by T lymphocytes	1.03E-11	ADORA2A,AIM2,CCL19,CCL5,CRLF2,CXCL10,IL15RA,IL1A,IL1B,IL2RA,IRF7,LAG3,MDK,PTGS2,TNFSF10	15
Immunological Disease,Organismal Injury and Abnormalities	Delayed hypersensitive reaction	1.04E-11	CCL5,CCR7,CLEC4D,CLEC4E,CXCL10,IDO1,IFITM1,IL12B,IL1B,IL27,MX1,NCF1,TNFSF10	13
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Activation of antigen presenting cells	1.05E-11	CCL20,CCL4,CCL5,CCR7,CD80,CLEC4D,CLEC4E,CXCL10,CXCL5,CXCL8,DDX58,IDO1,IL1B,IRF4,NAMPT,PTGES,PTGS2,STAT4,THBS1,TNFSF10,WNT5A	21
Cell-To-Cell Signaling and Interaction,Cellular Movement,Immune Cell Trafficking	Attraction of antigen presenting cells	1.24E-11	CCL19,CCL20,CCL4,CCL5,CXCL10,IL12B,IL1B,VCAN	8
Hematological System Development and Function,Tissue Morphology	Quantity of myeloid cells	1.36E-11	ADORA2A,CD226,CLEC4E,CRLF2,CXCL10,CXCL2,CXCL8,DDX58,EBI3,FPR2,IL12B,IL1A,IL1B,IL2RA,IRF4,JAK3,MDK,PDE4B,PLAC8,PTGES,PTGIR,PTGS2,SERPINB2,SOCS3,STAT4,THBS1,TNFSF10,WNT5A	28
Cell Signaling	Replication of viral replicon	1.36E-11	APOBEC3A,CCL5,IFIT1,IFITM1,ISG15,ISG20,MX1,OASL,PTGS2,RSAD2	10
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Trafficking of leukocytes	1.59E-11	CCL19,CCL20,CCL4,CCL5,CCR7,CXCL1,CXCL10,CXCL13,CXCL3,ENPP2	10
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Migration of dendritic cells	1.60E-11	CCL19,CCL20,CCL4,CCL5,CCR7,CD38,CD80,CXCL10,CXCL13,FPR2,IL12B,IL1B,PDPN	13
Cancer,Hematological Disease,Organismal Injury and Abnormalities	Neoplasia of blood cells	1.63E-11	ADAM19,ADORA2A,AIM2,ANGPTL4,ANKRD22,APOBEC3A,BCL2L14,C1QTNF1,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL8,CYP2E1,DDX58,EBI3,EPSTI1,FPR2,HAPLN3,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,LAG3,MN1,MX1,MYO1G,NAMPT,NSUN7,OASL,PAX5,PDE4B,PLAC8,PLXNA4,PTGS2,RSAD2,SERPINB2,SIGLEC10,SLC1A2,SLC8A3,SNAI1,SOCS2,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,UNC13A,VCAN,XAF1	76
Cell-mediated Immune Response,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development	Development of helper T lymphocytes	1.82E-11	CD226,DDX58,IL12B,IL1A,IL1B,IL27,IRF4,JAK3,SOCS2,SOCS3,STAT4	11
Gastrointestinal Disease,Organismal Injury and Abnormalities	Chronic periodontal disease	1.83E-11	CCL4L1/CCL4L2,CCL5,CXCL8,G0S2,IL1A,IL1B,IL7R,NKG7,PDE4B,PLAC8,PTGS2,SOCS3	12
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking	Adhesion of mononuclear leukocytes	1.88E-11	CCL19,CCL20,CCL4,CCL5,CCR7,CD80,CXCL13,CXCL8,IL1A,IL1B,IL7R,JAK3,MYO1G,THBS1	14
Cancer,Hematological Disease,Organismal Injury and Abnormalities	Hematologic cancer of cells	1.90E-11	ADAM19,ADORA2A,AIM2,APOBEC3A,C1QTNF1,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD300E,CD38,CD70,CD80,CEMIP,CMPK2,CRLF2,CXCL10,CXCL13,CXCL8,DDX58,EBI3,ENPP2,FPR2,HAPLN3,IDO1,IFI44L,IFIT2,IFIT3,IFITM1,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,LAG3,MX1,MYO1G,NAMPT,OASL,PAX5,PDE4B,PLAC8,PLXNA4,PTGS2,RSAD2,SIGLEC10,SLC1A2,SLC8A3,STAT4,THBS1,TNFSF10,TRAF1,VCAN,XAF1	60
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	Mature T-cell neoplasm	1.93E-11	ADAM19,AIM2,C1QTNF1,CCL19,CCL20,CCL8,CCR7,CD38,CXCL10,CXCL13,CXCL8,EBI3,IDO1,IFI44L,IFIT2,IFIT3,IFITM1,IL2RA,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,MX1,OASL,PLXNA4,RSAD2,STAT4,TNFSF10	30
Cell Death and Survival,Organismal Injury and Abnormalities	Cell viability of leukocytes	1.98E-11	AIM2,CCL4,CCR7,CD38,CD80,CXCL8,HSH2D,IDO1,IL1B,IL27,IL7R,IRF4,JAK3,MX1,SERPINB2,STAT4,TNFSF10,WNT5A	18
Cancer,Hematological Disease,Organismal Injury and Abnormalities	Myeloid or lymphoid neoplasm	2.03E-11	ADAM19,ADORA2A,AIM2,ANGPTL4,ANKRD22,APOBEC3A,APOL3,BCL2L14,C1QTNF1,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL8,CYP2E1,DDX58,EBI3,EPSTI1,FPR2,HAPLN3,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,LAG3,MN1,MX1,MYO1G,NAMPT,NSUN7,OASL,PAX5,PDE4B,PLAC8,PLXNA4,PTGS2,RSAD2,SERPINB2,SIGLEC10,SLC1A2,SLC8A3,SNAI1,SOCS2,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,UNC13A,VCAN,XAF1,ZBP1	78
Cell-To-Cell Signaling and Interaction	Binding of cell surface	2.16E-11	CCL19,CCL20,CCL5,CCL8,CXCL1,CXCL10,CXCL13,CXCL3,CXCL8,TNFSF10	10
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Recruitment of dendritic cells	2.21E-11	CCL19,CCL20,CCL4,CCL5,CXCL10,CXCL3,CXCL8,FPR2	8
Cell-To-Cell Signaling and Interaction,Inflammatory Response	Response of phagocytes	2.72E-11	ADORA2A,CCL19,CCL20,CCL4,CCL5,CD38,CD80,CXCL1,CXCL10,CXCL3,CXCL8,DDX58,HSH2D,IL1B,ISG15,SIGLEC1,THBS1,WNT5A	18
Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology	Quantity of innate lymphoid cells	2.86E-11	ADORA2A,CALHM6,CD70,CD80,EBI3,IL12B,IL15RA,IL1B,IL2RA,IL7R,ISG15,JAK3,PTGIR	13
Cell-mediated Immune Response,Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Recruitment of T lymphocytes	3.66E-11	CCL19,CCL20,CCL4,CCL5,CCR7,CXCL10,CXCL13,CXCL3,CXCL8,DDX58,IL1B	11
Organismal Injury and Abnormalities,Tissue Morphology	Size of lesion	4.39E-11	ADORA2A,AIM2,C1QTNF1,CA12,CCL19,CD226,CD38,CXCL3,EBI3,EHF,FSIP1,IDO1,IL1A,IL1B,MDK,NAMPT,PANX2,PTGES,PTGS2,SLC8A3,SOCS3,THBS1,TNFSF10	23
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Recruitment of monocytes	4.45E-11	CCL19,CCL20,CCL23,CCL4,CCL5,CXCL10,CXCL3,CXCL8,FPR2,IL1B	10
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemotaxis of dendritic cells	4.58E-11	CCL19,CCL20,CCL4,CCL5,CCR7,CD38,CXCL10,FPR2,IL1A,IL1B,SLAMF1	11
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function	Immune response of lymphocytes	4.60E-11	ADORA2A,CCR7,CD226,CD38,CD80,CXCL8,IL12B,IL1B,IL2RA,IL7R,ITGB8,NAMPT,SOCS3	13
Organismal Injury and Abnormalities,Tissue Morphology	Morphology of lesion	4.95E-11	ADORA2A,AIM2,C1QTNF1,CA12,CCL19,CD226,CD38,CXCL3,EBI3,EHF,FSIP1,HPN,IDO1,IL1A,IL1B,MDK,NAMPT,PANX2,PTGES,PTGS2,SLC8A3,SOCS3,THBS1,TNFSF10	24
Infectious Diseases,Organismal Injury and Abnormalities,Respiratory Disease	Viral respiratory infection	5.17E-11	CCL20,CCL4,CCL5,CCR7,CD70,CLEC4E,CXCL10,CXCL8,DDX58,IL1A,IL1B,IRF7,NCF1,S100A12,STAT4	15
Protein Synthesis	Production of protein	5.41E-11	CCR7,CD80,CLEC4D,CLEC4E,CRLF2,CXCL10,DDX58,FPR2,IFIT2,IL2RA,IRF4,IRF7,JAK3,PTGS2,RSAD2,SIGLEC1,SIGLEC10,THBS1,TNFSF10	19
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Migration of macrophages	6.20E-11	CCL19,CCL4,CCL5,CXCL1,CXCL10,CXCL3,CXCL8,IL12B,MDK,PTGS2,VCAN,WNT5A	12
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	T-cell malignant neoplasm	6.41E-11	ADAM19,ADORA2A,AIM2,APOL3,C1QTNF1,CCL19,CCL20,CCL8,CCR7,CD38,CRLF2,CXCL10,CXCL13,CXCL8,EBI3,IDO1,IFI44L,IFIT2,IFIT3,IFITM1,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,MX1,MYO1G,OASL,PAX5,PLXNA4,RSAD2,STAT4,TNFSF10,ZBP1	37
Cell-To-Cell Signaling and Interaction,Inflammatory Response	Immune response of phagocytes	6.47E-11	ADORA2A,CCL19,CCL20,CCL4,CD38,CD80,CXCL1,CXCL10,CXCL3,CXCL8,DDX58,HSH2D,IL1B,ISG15,SIGLEC1,THBS1,WNT5A	17
Cellular Movement	Chemotaxis of leukemia cell lines	6.68E-11	CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CXCL1,CXCL13,CXCL8,FPR2	10
Cell Signaling	Viral life cycle	7.06E-11	APOBEC3A,CCL5,IFIT1,IFITM1,ISG15,ISG20,LAMP3,MX1,OASL,PTGS2,RSAD2	11
Organismal Injury and Abnormalities,Respiratory Disease	Damage of lung	7.36E-11	ADORA2A,AIM2,CCL5,CFB,CMPK2,CXCL10,CXCL8,CYP2E1,HSH2D,IL12B,IL1A,IL1B,JAK3,NAMPT,NCF1,PTGS2,SOCS3,TNFAIP6	18
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Transmigration of phagocytes	7.39E-11	ADORA2A,CCL19,CCL4,CCL5,CCR7,CXCL1,CXCL2,CXCL3,CXCL5,CXCL8,IL1B,SOCS3	12
Cell Signaling,Molecular Transport,Vitamin and Mineral Metabolism	Mobilization of Ca2+	7.97E-11	ADORA2A,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD38,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,PTGIR,WNT5A	19
Cellular Movement	Cell movement of tumor cell lines	8.15E-11	ANGPTL4,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CEMIP,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,EBI3,EHF,ENPP2,EREG,FPR2,FSIP1,IFIT2,IL1A,IL1B,ISG15,MDK,MX1,NAMPT,PAX5,PDPN,PTGS2,SNAI1,SOCS3,THBS1,TNFAIP6,TNFSF10,VCAN,WFDC21P,WNT5A	41
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Lymphoid Tissue Structure and Development	Expansion of lymphocytes	8.17E-11	ADORA2A,CCR7,CD70,CD80,IL15RA,IL1B,IL27,IL2RA,IL7R,JAK3,LAG3,MDK,SIGLEC10,SLAMF1,STAT4	15
Cellular Movement,Hematological System Development and Function,Hypersensitivity Response,Immune Cell Trafficking	Cell movement of eosinophils	8.79E-11	CCL19,CCL4,CCL5,CRLF2,CXCL10,CXCL2,CXCL8,IL12B,IL1B,IL27,IRF7,PTGIR	12
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Lymphoid Tissue Structure and Development	Expansion of T lymphocytes	8.91E-11	ADORA2A,CCR7,CD70,CD80,IL15RA,IL1B,IL27,IL2RA,IL7R,JAK3,LAG3,MDK,SLAMF1,STAT4	14
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Transmigration of leukocytes	8.91E-11	ADORA2A,CCL19,CCL4,CCL5,CCR7,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,ENPP2,IL1B,SOCS3	14
Gastrointestinal Disease,Inflammatory Disease,Organismal Injury and Abnormalities	Inflammatory Bowel Disease	9.14E-11	ADORA2A,CD80,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,HS3ST3B1,IDO1,IL12B,IL1A,IL1B,IL2RA,ITGB8,JAK3,PAX5,PDE4B,PTGS2,SLAMF1,SOCS3,STAT4,ZBP1	23
Cell-mediated Immune Response,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development	Differentiation of helper T lymphocytes	9.25E-11	CCL5,CD80,CLEC4E,CXCL1,DDX58,IL12B,IL1B,IL27,IL2RA,IL7R,IRF4,JAK3,RSAD2,SOCS2,SOCS3,STAT4	16
Organismal Injury and Abnormalities,Respiratory Disease	Lung injury	1.22E-10	ADORA2A,AIM2,CCL5,CFB,CMPK2,CXCL10,CXCL8,CYP2E1,HSH2D,IL1A,IL1B,JAK3,NAMPT,NCF1,PTGS2,SOCS3,TNFAIP6	17
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cell movement of PBMCs	1.27E-10	CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CXCL10,CXCL13,CXCL8,FPR2	10
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	Non-Hodgkin lymphoma	1.43E-10	ADAM19,ADORA2A,AIM2,APOBEC3A,C1QTNF1,CCL19,CCL20,CCL5,CCL8,CCR7,CD38,CD70,CXCL10,CXCL13,CXCL8,DDX58,EBI3,IDO1,IFI44L,IFIT2,IFIT3,IFITM1,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,MX1,MYO1G,OASL,PAX5,PLXNA4,PTGS2,RSAD2,SIGLEC10,SLC8A3,STAT4,TRAF1	42
Connective Tissue Disorders,Immunological Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Polyarticular juvenile rheumatoid arthritis	1.44E-10	CCL20,CCL4,CCL5,CD80,FPR2,IL1B,JAK3,PTGS2,S100A12,SLC1A2,THBS1	11
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Migration of granulocytes	1.46E-10	ADORA2A,CCL19,CCL4,CCL5,CCR7,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,IL1B,PDE4B,SOCS3	14
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function	Binding of mononuclear leukocytes	1.58E-10	CCL19,CCL20,CCL4,CCL5,CCR7,CD80,CXCL10,CXCL13,CXCL8,IL1A,IL1B,IL7R,JAK3,MYO1G,THBS1	15
Cell-mediated Immune Response,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development	Generation of helper T lymphocytes	1.62E-10	DDX58,IL12B,IL1A,IL1B,IL27,IRF4,JAK3,SOCS2,SOCS3,STAT4	10
Humoral Immune Response,Protein Synthesis	Production of antibody	1.66E-10	CCR7,CD80,CLEC4D,CLEC4E,CRLF2,CXCL10,FPR2,IFIT2,IL2RA,IRF4,IRF7,JAK3,PTGS2,RSAD2,SIGLEC1,SIGLEC10,THBS1,TNFSF10	18
Cancer,Organismal Injury and Abnormalities,Reproductive System Disease	HER2 negative hormone receptor negative breast cancer	1.68E-10	CEMIP,CMPK2,CXCL10,CXCL2,CXCL8,EPSTI1,HPN,IFI44L,IL1A,IL1B,MT1E,MT1M,MT1X,MX1,PTGS2,RSAD2,THBS1,TNFSF10,VCAN	19
Cancer,Organismal Injury and Abnormalities	Lymphoreticular neoplasm	1.79E-10	ADAM19,ADORA2A,AIM2,ANGPTL4,ANKRD22,APOBEC3A,BCL2L14,C1QTNF1,CCL19,CCL20,CCL5,CCL8,CCR7,CD38,CD70,CD80,CXCL10,CXCL13,CXCL8,CYP2E1,DDX58,EBI3,ENPP2,FPR2,HAPLN3,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,JAK3,LAD1,LAG3,MN1,MX1,MYO1G,NAMPT,NSUN7,OASL,PAX5,PDE4B,PLAC8,PLXNA4,PTGS2,RSAD2,SERPINB2,SIGLEC10,SLC8A3,SNAI1,STAT4,THBS1,TNFAIP6,TNFSF10,TRAF1,UNC13A	64
Dermatological Diseases and Conditions,Organismal Injury and Abnormalities	Chronic small plaque psoriasis	1.82E-10	CCL20,CXCL10,CXCL8,IL12B,IL2RA,S100A12	6
Dermatological Diseases and Conditions,Organismal Injury and Abnormalities	Chronic large plaque psoriasis	1.82E-10	CCL20,CXCL10,CXCL8,IL12B,IL2RA,S100A12	6
Cell-To-Cell Signaling and Interaction,Cellular Movement,Immune Cell Trafficking	Attraction of macrophages	1.82E-10	CCL4,CCL5,CXCL10,IL12B,IL1B,VCAN	6
Connective Tissue Disorders,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Juvenile arthritis	1.85E-10	CCL20,CCL4,CCL5,CD80,FPR2,IL12B,IL1A,IL1B,JAK3,PDE4B,PTGS2,S100A12,SLC1A2,THBS1,TRAF1	15
Cellular Development,Hematological System Development and Function,Lymphoid Tissue Structure and Development	Maturation of dendritic cells	2.01E-10	CCL19,CCL20,CCL5,CD80,DDX58,IL12B,IL1A,IL1B,IL2RA,SOCS2,THBS1,TNFSF10	12
Organismal Injury and Abnormalities,Respiratory Disease	Acute respiratory disorder	2.08E-10	ADORA2A,CA12,CCL5,CCR7,CLEC4E,CMPK2,CXCL10,CXCL8,IL1A,IL1B,JAK3,NAMPT,NCF1,PDE4B,PTGIR,PTGS2,S100A12,STAT4,TNFAIP6	19
Cellular Movement	Transmigration of cells	2.28E-10	ADORA2A,CCL19,CCL4,CCL5,CCR7,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,ENPP2,IL1B,ISG15,SOCS3	15
Cell-mediated Immune Response,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cell movement of CD4+ T-lymphocytes	2.31E-10	ADORA2A,CCL19,CCL4,CCL5,CCR7,CRLF2,IL12B,IL15RA,IRF7,LAG3	10
Digestive System Development and Function,Gastrointestinal Disease,Hepatic System Development and Function,Hepatic System Disease,Inflammatory Disease,Inflammatory Response,Organ Development,Organismal Injury and Abnormalities,Psychological Disorders	Severe alcoholic hepatitis	2.32E-10	ADORA2A,CXCL10,IFIT2,IFIT3,IRF7,ISG15,PDE4B	7
Cell-To-Cell Signaling and Interaction,Cellular Movement,Immune Cell Trafficking	Attraction of mononuclear leukocytes	2.87E-10	CCL19,CCL4,CCL5,CXCL10,CXCL13,CXCL8,FPR2,IL1B	8
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Attraction of neutrophils	3.11E-10	CCL4,CCL5,CXCL1,CXCL10,CXCL3,CXCL5,CXCL8	7
Organismal Injury and Abnormalities,Reproductive System Disease	Abortion	3.32E-10	CCR7,CXCL10,CXCL13,CXCL8,EREG,GBP4,GBP5,IFIT2,IL12B,IL1B,IL2RA,ITGB8,MX1,MX2,PTGS2,WNT5A	16
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemotaxis of monocytes	3.37E-10	CCL20,CCL23,CCL4,CCL5,CCL8,CXCL10,CXCL3,CXCL8,FPR2,IL1B,S100A12	11
Organismal Injury and Abnormalities,Respiratory Disease	Lower respiratory tract disorder	3.42E-10	ADAM19,ADORA2A,CA12,CCL5,CXCL3,CXCL8,CYP2E1,IL1B,IL2RA,IL7R,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,PDE4B,PDPN,PTGIR,PTGS2,WNT5A	22
Cellular Movement	Migration of myeloid cells	3.43E-10	ADORA2A,CCL19,CCL4,CCL5,CCR7,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,IL1B,MDK,PDE4B,SOCS3	15
Hematological System Development and Function,Inflammatory Response,Tissue Morphology	Quantity of neutrophils	3.52E-10	ADORA2A,CLEC4E,CRLF2,CXCL2,IL1A,IL1B,IL2RA,IRF4,JAK3,MDK,PDE4B,PLAC8,PTGIR,SERPINB2,SOCS3,THBS1,TNFSF10	17
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Influx of leukocytes	3.62E-10	ADORA2A,CCL4,CXCL1,CXCL2,CXCL3,CXCL5,IL12B,IL1B,IRF4,IRF7	10
Organismal Injury and Abnormalities,Reproductive System Disease	Early missed abortion	3.72E-10	CCR7,CXCL10,CXCL13,EREG,GBP4,GBP5,IFIT2,IL12B,IL1B,IL2RA,ITGB8,MX1,MX2,WNT5A	14
Infectious Diseases,Organismal Injury and Abnormalities	Replication of Hepatitis C virus	4.51E-10	CYP2E1,DDX58,IFI27,IFIT1,IFITM1,ISG15,MAP1LC3A,RSAD2,SOCS2,SOCS3	10
Infectious Diseases,Organismal Injury and Abnormalities	Replication of HIV-1	4.64E-10	CCL4,CCL5,CD38,CXCL8,HERC5,IL1B,IL27,IRF7,PTGS2,S100A12,SOCS3,TNFSF10	12
Humoral Immune Response,Protein Synthesis	Quantity of immunoglobulin	4.85E-10	CCR7,CD80,CLEC4D,CLEC4E,CRLF2,CXCL10,FPR2,IFIT2,IL2RA,IRF4,JAK3,PTGS2,RSAD2,SIGLEC1,SIGLEC10,THBS1,TNFSF10	17
Cellular Development	Maturation of cells	4.90E-10	ADORA2A,CCL19,CCL20,CCL5,CD80,DDX58,EREG,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,ITGB8,PTGS2,SOCS2,THBS1,TNFSF10,UNC13A,WNT5A	22
Dermatological Diseases and Conditions,Organismal Injury and Abnormalities	Abnormality of skin morphology	5.12E-10	CCL19,CCL20,CCL4,CD226,CFB,CXCL1,CXCL8,EBI3,FPR2,IFI27,IFIT1,IFITM1,IL12B,IL1A,IL1B,ITGB8,JAK3,MX1,PTGIR,PTGS2,THBS1	21
Cellular Development,Cellular Growth and Proliferation	Expansion of blood cells	5.18E-10	ADORA2A,CCR7,CD70,CD80,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,JAK3,LAG3,MDK,SIGLEC10,SLAMF1,STAT4	16
Cellular Development,Cellular Growth and Proliferation	Cell proliferation of tumor cell lines	5.31E-10	AIM2,ANGPTL4,APOBEC3A,CCL20,CD38,CD80,CEMIP,CMPK2,CRLF2,CXCL1,CXCL10,CXCL8,DDX58,EHF,EREG,ETV7,FPR2,FSIP1,G0S2,HPN,IDO1,IFIT1,IFIT2,IFITM1,IL15RA,IL1A,IL1B,IL27,IL2RA,IRF4,ITGB8,JAK3,KCNJ5,MAP1LC3A,MDK,MT2A,NAMPT,NKX3-1,PANX2,PAX5,PLAC8,PLXNA4,PRAME,PTGES,PTGS2,SERPINB2,SNAI1,SOCS3,THBS1,TNFSF10,VCAN,WFDC21P,WNT5A	53
Cell-To-Cell Signaling and Interaction	Response of myeloid cells	6.16E-10	ADORA2A,CCL20,CCL4,CD38,CXCL1,CXCL10,CXCL3,CXCL8,DDX58,HSH2D,IL1B,IRF4,ISG15,SIGLEC1,THBS1,WNT5A	16
Cellular Movement	Cell movement of progenitor cells	7.34E-10	CCL19,CCL20,CCL4,CCL5,CCL8,CD38,CXCL10,CXCL13,CXCL5,CXCL8,PTGIR	11
Dermatological Diseases and Conditions,Organismal Injury and Abnormalities	Active stage psoriasis	7.39E-10	CXCL8,G0S2,NAMPT,PTGS2,SERPINB2,TNFAIP6	6
Cellular Movement,Hematological System Development and Function	Cell movement of hematopoietic progenitor cells	8.41E-10	CCL19,CCL20,CCL4,CCL5,CCL8,CD38,CXCL10,CXCL13,CXCL5,CXCL8	10
Organismal Injury and Abnormalities,Renal and Urological Disease	Chronic renal impairment	9.80E-10	ADORA2A,CA12,CD80,CXCL8,IDO1,IL1A,IL1B,IL2RA,PDE4B,PTGIR,PTGS2,SLC2A6,SOCS2,WNT5A	14
Gastrointestinal Disease,Organismal Injury and Abnormalities	Periodontal disease	1.01E-09	CCL4L1/CCL4L2,CCL5,CXCL8,G0S2,IL12B,IL1A,IL1B,IL7R,NKG7,PDE4B,PLAC8,PTGS2,SOCS3	13
Cell Death and Survival,Organismal Injury and Abnormalities	Apoptosis of tumor cell lines	1.08E-09	ADORA2A,AIM2,ANGPTL4,APOBEC3A,BCL2L14,CD226,CEMIP,CXCL8,CYP2E1,DDX58,EHF,ENPP2,EREG,FSIP1,G0S2,GBP5,HPN,HSH2D,IDO1,IL15RA,IL1A,IL1B,IRF4,JAK3,LAG3,MDK,MT1F,MT2A,PAX5,PDE4B,PLXNA4,PRAME,PTGS2,SNAI1,SOCS3,THBS1,TNFSF10,TRAF1,VCAN,WNT5A,XAF1	41
Infectious Diseases,Organismal Injury and Abnormalities	Infection by rotavirus	1.10E-09	CCL4,CCL5,CXCL1,CXCL10,CXCL8,PTGS2	6
Cellular Movement	Migration of tumor cells	1.13E-09	CCL19,CCL5,CCR7,CXCL1,CXCL10,CXCL13,CXCL8,ENPP2,NKX3-1,PTGS2,SERPINB2,SNAI1,THBS1,VCAN,WNT5A	15
Cellular Development,Cellular Growth and Proliferation	Proliferation of progenitor cells	1.19E-09	CCL19,CCL20,CCL23,CCL4,CXCL10,CXCL2,CXCL3,CXCL8,IL1A,IL1B,IL27,IL7R,IRF4,JAK3,PTGS2,SOCS2,SOCS3,TNFSF10,WNT5A	19
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function	Binding of lymphocytes	1.20E-09	CCL19,CCL20,CCL4,CCL5,CCR7,CD80,CXCL10,CXCL13,IL1B,IL7R,JAK3,MYO1G,THBS1	13
Digestive System Development and Function,Gastrointestinal Disease,Hepatic System Development and Function,Hepatic System Disease,Inflammatory Disease,Inflammatory Response,Metabolic Disease,Organ Development,Organismal Injury and Abnormalities,Psychological Disorders	Alcoholic steatohepatitis	1.26E-09	CXCL10,IFIT2,IFIT3,IRF7,ISG15	5
Cellular Movement	Influx of myeloid cells	1.27E-09	ADORA2A,CCL4,CXCL1,CXCL2,CXCL5,IL12B,IL1B,IRF4,IRF7	9
Cell-mediated Immune Response,Lymphoid Tissue Structure and Development	Frequency of T lymphocytes	1.29E-09	CCL19,CCL20,CCR7,CD226,CD70,CRLF2,EBI3,GCH1,IDO1,IL1B,TNFSF10	11
Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Renal and Urological Disease	Nephritis	1.31E-09	ADORA2A,AIM2,CCL4,CCL5,CCR7,CD80,CFB,CXCL8,EPSTI1,HERC5,IDO1,IRF7,ISG20,MDK,PDE4B,PTGS2,SIGLEC10,SLC2A6,SNAI1	19
Hematological System Development and Function,Tissue Development	Accumulation of myeloid cells	1.33E-09	CCL5,CXCL1,CXCL10,CXCL2,CXCL3,CXCL8,IL12B,IL1B,IRF4,MDK,NCF1,PTGS2,THBS1,TNFSF10	14
Hematological Disease,Organismal Injury and Abnormalities	Hemorrhagic disease	1.41E-09	CCL4,CCL5,CFB,CXCL1,CXCL10,CXCL13,CXCL8,IL12B,IRF7,ISG15,KCNJ5,MX2,PTGIR,PTGS2,SERPINB2,THBS1,TNFSF10	17
Cancer,Organismal Injury and Abnormalities	Extrapancreatic malignant tumor	1.46E-09	ABTB2,ACOD1,ADAM19,ADGRE1,ADORA2A,AIM2,ANGPTL4,ANKRD22,ANKRD33B,APOBEC3A,APOL3,BCL2L14,BTBD11,C1QTNF1,C6orf223,CA12,CALHM6,CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EHF,ENPP2,EPSTI1,EREG,ETV7,FPR2,FSIP1,G0S2,GBP4,GBP5,GCH1,GFPT2,HAPLN3,HELZ2,HERC5,HESX1,HPN,HS3ST3B1,HSH2D,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,ITGB8,JAK3,KCNA2,KCNJ5,LAD1,LAG3,LAMP3,MAP1LC3A,MCOLN2,MDK,MN1,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,MX1,MX2,MYO1G,NAMPT,NCF1,NKG7,NKX3-1,NSUN7,OASL,PANX2,PAX5,PDE4B,PDPN,PLAC8,PLXNA4,PRAME,PTGES,PTGIR,PTGS2,RSAD2,S100A12,SERPINB2,SIGLEC1,SIGLEC10,SLAMF1,SLC1A2,SLC2A6,SLC38A5,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TNIP3,TRAF1,UNC13A,VCAN,WFDC21P,WNT5A,XAF1,ZBP1	145
Cancer,Organismal Injury and Abnormalities	Growth of solid tumor	1.49E-09	ADORA2A,CD38,CD70,CD80,CXCL1,CXCL3,CXCL5,GCH1,HPN,IDO1,IL12B,IL1A,IL1B,NKX3-1,PTGES,PTGS2,SNAI1,SOCS3,THBS1,TNFSF10,VCAN,WNT5A	22
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Attraction of monocytes	1.60E-09	CCL4,CCL5,CXCL10,CXCL8,FPR2,IL1B	6
Cancer,Organismal Injury and Abnormalities	Growth of tumor	1.61E-09	ADORA2A,AIM2,ANGPTL4,CA12,CCL5,CD226,CD38,CD70,CD80,CXCL1,CXCL3,CXCL5,CXCL8,EHF,EPSTI1,GCH1,HPN,IDO1,IL12B,IL1A,IL1B,IL27,IRF4,ITGB8,LAG3,MAP1LC3A,NAMPT,NKX3-1,PTGES,PTGS2,SNAI1,SOCS3,THBS1,TNFSF10,VCAN,WFDC21P,WNT5A	37
Connective Tissue Disorders,Immunological Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Juvenile rheumatoid arthritis	1.62E-09	CCL20,CCL4,CCL5,CD80,FPR2,IL1A,IL1B,JAK3,PDE4B,PTGS2,S100A12,SLC1A2,THBS1,TRAF1	14
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Hematopoiesis	Proliferation of hematopoietic progenitor cells	1.66E-09	CCL20,CCL23,CCL4,CXCL10,CXCL2,CXCL3,CXCL8,IL1A,IL1B,IL27,IL7R,IRF4,JAK3,PTGS2,SOCS2,WNT5A	16
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Migration of neutrophils	1.83E-09	ADORA2A,CCL19,CCL5,CCR7,CXCL1,CXCL2,CXCL3,CXCL5,CXCL8,IL1B,PDE4B,SOCS3	12
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Recruitment of macrophages	2.21E-09	CCL4,CCL5,CLEC4E,CXCL10,CXCL8,IDO1,IL1B,MCOLN2,MDK,SNAI1,THBS1	11
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Priming of leukocytes	2.29E-09	CD38,CD80,CXCL8,IL12B,IL15RA,IL1A,IL1B,IRF4,SIGLEC1	9
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Activation of dendritic cells	2.38E-09	CCL20,CCL4,CCR7,CD80,CLEC4D,CXCL8,DDX58,IDO1,IL1B,STAT4,TNFSF10	11
Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Progressive neuromuscular disease	2.40E-09	ADORA2A,CCL5,CD38,CXCL1,EPSTI1,GCH1,IDO1,IFIT1,IL1A,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,KCNA2,LAG3,MX1,PDE4B,PTGS2,RSAD2	21
Cell Death and Survival,Organismal Injury and Abnormalities	Cell death of tumor cell lines	2.42E-09	ADORA2A,AIM2,ANGPTL4,APOBEC3A,BCL2L14,CD226,CEMIP,CXCL8,CYP2E1,DDX58,EHF,ENPP2,EREG,FSIP1,G0S2,GBP5,HPN,HSH2D,IDO1,IL12B,IL15RA,IL1A,IL1B,IRF4,JAK3,LAG3,MCOLN2,MDK,MT1F,MT1X,MT2A,NAMPT,PAX5,PDE4B,PLXNA4,PRAME,PTGS2,SNAI1,SOCS3,THBS1,TNFSF10,TRAF1,VCAN,WNT5A,XAF1,ZBP1	46
Organismal Injury and Abnormalities,Reproductive System Disease	Disorder of pregnancy	2.51E-09	ADORA2A,APOL3,CCL20,CCR7,CXCL10,CXCL13,CXCL5,CXCL8,CYP2E1,ENPP2,EREG,GBP4,GBP5,IFIT1,IFIT2,IFITM1,IL12B,IL1A,IL1B,IL2RA,ITGB8,MX1,MX2,PDE4B,PLAC8,PTGIR,PTGS2,SOCS3,THBS1,WNT5A	30
Cell-To-Cell Signaling and Interaction,Cellular Growth and Proliferation,Hematological System Development and Function	Stimulation of mononuclear leukocytes	2.83E-09	CCL19,CCL20,CCL5,CD70,CD80,CLEC4E,CXCL10,IL12B,IL1B,IL27,SLAMF1,TNFSF10	12
Inflammatory Disease,Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Multiple Sclerosis	2.97E-09	CD38,CXCL1,EPSTI1,IDO1,IFIT1,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,KCNA2,LAG3,MX1,PTGS2,RSAD2	16
Cell Signaling,Cellular Function and Maintenance,Molecular Transport,Vitamin and Mineral Metabolism	Flux of Ca2+	3.09E-09	CCL19,CCL20,CCL23,CCL4,CCL5,CD226,CD38,CXCL1,CXCL10,CXCL13,CXCL3,CXCL5,CXCL8,FPR2,IL1B,KCNJ5,SLC8A3	17
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemoattraction of antigen presenting cells	3.17E-09	CCL19,CCL20,CCL4,CCL5,CXCL10,IL12B	6
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Tissue Development	Differentiation of phagocytes	3.54E-09	CCL23,CXCL10,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ITGB8,JAK3,MDK,PAX5,PLAC8,SIGLEC10,SOCS3,TNFSF10	17
Humoral Immune Response,Protein Synthesis	Quantity of IgG	3.65E-09	CCR7,CD80,CLEC4D,CLEC4E,CXCL10,FPR2,IFIT2,IL2RA,IRF4,JAK3,PTGS2,RSAD2,SIGLEC10,TNFSF10	14
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking	Adhesion of lymphocytes	3.66E-09	CCL19,CCL20,CCL4,CCR7,CD80,CXCL13,IL1B,IL7R,JAK3,MYO1G,THBS1	11
Cell Morphology	Polarization of helper T lymphocytes	4.17E-09	EBI3,IL12B,IL1A,IL1B,IRF4,SLAMF1,STAT4	7
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Cell movement of monocytes	4.20E-09	CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CXCL10,CXCL3,CXCL8,FPR2,IL1B,MDK,S100A12	13
Lymphoid Tissue Structure and Development	Frequency of lymphocytes	4.32E-09	CCL19,CCL20,CCR7,CD226,CD70,CRLF2,CXCL10,EBI3,GCH1,IDO1,IL1B,TNFSF10	12
Cellular Function and Maintenance	Ion homeostasis of cells	4.80E-09	C1QTNF1,CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CCR7,CD226,CD38,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,FPR2,IL1A,IL1B,JAK3,KCNJ5,MT2A,SLC8A3	24
Inflammatory Response	Proinflammatory response	5.06E-09	CCL4,CCL5,CXCL10,CXCL3,CXCL8,IL1A,IL1B	7
Connective Tissue Disorders,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Active stage arthritis	5.06E-09	CD80,IL12B,IL1A,IL1B,JAK3,PDE4B,PTGS2	7
Cellular Movement	Cell movement of leukemia cell lines	5.14E-09	CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CXCL1,CXCL10,CXCL13,CXCL8,FPR2,WNT5A	12
Inflammatory Disease,Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Relapsing-remitting multiple sclerosis	5.15E-09	EPSTI1,IFIT1,IL2RA,IRF7,ISG15,KCNA2,LAG3,MX1,PTGS2,RSAD2	10
Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology	Quantity of CD4+ T-lymphocytes	6.11E-09	ADORA2A,AIM2,CCL5,CCR7,CD70,CXCL10,IL15RA,IL27,IRF4,ITGB8,JAK3,LAG3,SIGLEC10,SOCS3,THBS1	15
Cell Death and Survival	Cell viability	6.15E-09	ADORA2A,AIM2,APOBEC3A,CCL4,CCL5,CCR7,CD38,CD80,CXCL1,CXCL10,CXCL2,CXCL3,CXCL8,EREG,GCH1,HSH2D,IDO1,IL1A,IL1B,IL27,IL7R,IRF4,JAK3,MCOLN2,MDK,MX1,NAMPT,NKX3-1,PLAC8,PRAME,PTGS2,SERPINB2,SLC1A2,SLC8A3,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFSF10,VCAN,WNT5A,XAF1	43
Tissue Development	Growth of epithelial tissue	6.21E-09	ADORA2A,AIM2,ANGPTL4,CCL5,CCR7,CXCL1,CXCL10,CXCL3,CXCL8,EREG,FPR2,HPN,IL1A,IL1B,ITGB8,MDK,NCF1,NKX3-1,PLXNA4,PTGIR,PTGS2,SNAI1,SOCS3,THBS1,TNFAIP6,TNFSF10,WNT5A	27
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Activation of monocytes	6.60E-09	CCL4,CCL5,CCL8,CD80,CXCL8,IL1B,IL27,S100A12,TNFSF10	9
Cellular Function and Maintenance	Function of phagocytes	6.87E-09	AIM2,CCL5,CCR7,CLEC4E,CXCL10,CXCL8,DDX58,FPR2,IDO1,IL12B,IL1B,IL27,JAK3,PTGS2,SLAMF1	15
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Transmigration of granulocytes	7.29E-09	ADORA2A,CXCL1,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,IL1B,SOCS3	9
Cell Morphology	Polarization of CD4+ T-lymphocytes	7.75E-09	CCL19,CCR7,IL1A,IL1B,IRF4,STAT4	6
Connective Tissue Disorders,Inflammatory Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Rheumatic disease of joint	8.02E-09	CD80,CXCL8,IL12B,IL1A,IL1B,JAK3,MN1,PAX5,PTGIR,PTGS2,SLC1A2,SOCS3,TNFSF10	13
Organismal Injury and Abnormalities,Renal and Urological Disease	Failure of kidney	8.34E-09	ADORA2A,CD80,CFB,CLEC4E,CXCL8,IDO1,IL2RA,IRF4,MDK,PDE4B,PTGS2,SLC2A6,SOCS2,THBS1,WNT5A	15
Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response,Tissue Development	Accumulation of mononuclear leukocytes	9.03E-09	ADORA2A,CCL5,CCR7,CD70,CD80,CXCL10,CXCL2,CXCL3,ENPP2,IL12B,IL2RA,TNFSF10	12
Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Neuromuscular disease with neuropathy	9.47E-09	ADORA2A,CCL5,CD38,CXCL1,EPSTI1,GCH1,IDO1,IFIT1,IL1A,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,KCNA2,LAG3,MX1,PDE4B,PTGS2,RSAD2	21
Cell-mediated Immune Response,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development	Differentiation of CD4+ T-lymphocytes	1.01E-08	CD226,CLEC4E,CXCL1,DDX58,IL1B,IL27,IL2RA,IL7R,IRF4,SOCS2,SOCS3,STAT4	12
Dermatological Diseases and Conditions,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	Lymphoproliferative disorder of the skin	1.01E-08	C1QTNF1,CCL8,CCR7,CXCL10,CXCL13,IDO1,IFITM1,IL2RA,IRF4,IRF7,ISG15,ISG20,JAK3,MX1,OASL,PLXNA4,RSAD2,STAT4	18
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Migration of PBMCs	1.04E-08	CCL19,CCL4,CCL5,CCR7,CXCL10,CXCL13,CXCL8	7
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Influx of granulocytes	1.13E-08	ADORA2A,CCL4,CXCL1,CXCL2,CXCL5,IL1B,IRF4,IRF7	8
Cellular Function and Maintenance	Function of antigen presenting cells	1.18E-08	AIM2,CCL5,CCR7,CLEC4E,CXCL10,DDX58,FPR2,IDO1,IL12B,IL1B,IL27,JAK3,PTGS2,SLAMF1	14
Cellular Movement	Homing of tumor cell lines	1.18E-08	CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CXCL1,CXCL13,CXCL3,CXCL8,FPR2,MDK	12
Cellular Movement,Hematological System Development and Function	Extravasation of leukocytes	1.28E-08	CCL4,CCL5,CXCL1,CXCL8,ENPP2,IL1B,MDK,TNFAIP6	8
Nutritional Disease,Organismal Injury and Abnormalities	Obesity	1.28E-08	ADGRE1,ADORA2A,ANGPTL4,C1QTNF1,CA12,CCL5,CD38,CXCL10,CXCL2,CXCL8,CYP2E1,EBI3,ENPP2,G0S2,HPN,IL1B,IL27,ISG20,JAK3,NAMPT,PDE4B,PTGS2,SOCS3,THBS1	24
Hematological System Development and Function,Lymphoid Tissue Structure and Development,Tissue Morphology	Quantity of natural killer cells	1.31E-08	ADORA2A,CALHM6,CD70,CD80,EBI3,IL12B,IL15RA,IL2RA,ISG15,JAK3	10
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function	Binding of T lymphocytes	1.36E-08	CCL19,CCL20,CCL4,CCL5,CCR7,CD80,CXCL10,IL1B,IL7R,JAK3,THBS1	11
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Trafficking of lymphocytes	1.44E-08	CCL4,CCL5,CCR7,CXCL10,CXCL13,CXCL3,ENPP2	7
Immunological Disease,Inflammatory Disease,Organismal Injury and Abnormalities	Atopic disease	1.46E-08	CCL20,CCL23,CCL5,CXCL8,FPR2,IFI27,IL1A,IL1B,IL2RA,JAK3,MX1,PDE4B,PTGS2,SOCS2,SOCS3,TNFSF10	16
Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response,Tissue Development	Accumulation of phagocytes	1.54E-08	CCL5,CCR7,CXCL1,CXCL10,CXCL2,CXCL3,CXCL8,IL12B,IL1B,IRF4,THBS1,TNFSF10	12
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemoattraction of granulocytes	1.68E-08	CCL5,CXCL1,CXCL10,CXCL3,CXCL5,CXCL8	6
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Influx of phagocytes	1.81E-08	CCL4,CXCL1,CXCL2,CXCL5,IL12B,IL1B,IRF4,IRF7	8
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Tissue Development	Hematopoiesis of phagocytes	1.92E-08	CCL23,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ITGB8,JAK3,MDK,PLAC8,SIGLEC10,TNFSF10	14
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Mobilization of phagocytes	2.12E-08	CCL20,CCL4,CXCL2,CXCL3,CXCL8,IL1B	6
Gastrointestinal Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	Ulcerative colitis	2.24E-08	ADORA2A,CD80,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,IL12B,IL1B,JAK3,PAX5,PDE4B,PTGS2,SOCS3	14
Cardiovascular System Development and Function,Organismal Development	Angiogenesis	2.25E-08	ADORA2A,ANGPTL4,CCL5,CCR7,CEMIP,CFB,CXCL1,CXCL10,CXCL2,CXCL5,CXCL8,ENPP2,EREG,FPR2,IL1A,IL1B,IL27,ISG15,ITGB8,MDK,NCF1,PDPN,PLXNA4,PTGES,PTGIR,PTGS2,S100A12,SNAI1,SOCS3,THBS1,TNFSF10,WNT5A	32
Cellular Movement,Hematological System Development and Function	Extravasation of phagocytes	2.31E-08	CCL4,CCL5,CXCL1,CXCL8,IL1B,MDK,TNFAIP6	7
Connective Tissue Disorders,Organismal Injury and Abnormalities	Damage of connective tissue	2.31E-08	CD70,CFB,CXCL8,IL1A,IL1B,NAMPT,PTGIR,PTGS2,TNFAIP6,VCAN	10
Infectious Diseases,Organismal Injury and Abnormalities	Replication of Herpesviridae	2.38E-08	CXCL10,CXCL3,DDX58,IL1B,ISG20,MX2,OASL,RSAD2,ZBP1	9
Cardiovascular System Development and Function	Development of vasculature	2.45E-08	ADAM19,ADORA2A,ANGPTL4,CCL5,CCR7,CEMIP,CFB,CXCL1,CXCL10,CXCL2,CXCL5,CXCL8,CYP2E1,ENPP2,EREG,FPR2,IL1A,IL1B,IL27,ISG15,ITGB8,MDK,NCF1,PDPN,PLXNA4,PTGES,PTGIR,PTGS2,S100A12,SNAI1,SOCS3,THBS1,TNFSF10,WNT5A	34
Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response,Tissue Development	Accumulation of T lymphocytes	2.48E-08	ADORA2A,CCL5,CCR7,CD70,CD80,CXCL10,CXCL3,IL12B,IL2RA,TNFSF10	10
Organismal Injury and Abnormalities	Wound	2.52E-08	ADORA2A,CCR7,CD38,CFB,EHF,EREG,IL1A,MDK,MT2A,PTGES,PTGS2,SERPINB2,THBS1,WNT5A	14
Cell-mediated Immune Response,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development	Differentiation of Th17 cells	2.65E-08	CLEC4E,CXCL1,DDX58,IL1B,IL27,IL2RA,IL7R,IRF4,SOCS3,STAT4	10
Cardiovascular Disease,Inflammatory Disease,Organismal Injury and Abnormalities	Vasculitis	2.65E-08	ADORA2A,CD80,CFB,CXCL8,IL12B,IL1A,IL1B,IL2RA,JAK3,STAT4	10
Organismal Injury and Abnormalities,Organismal Survival	Organismal death	2.67E-08	ADAM19,ADORA2A,AIM2,ANGPTL4,APOBEC3A,CA12,CD226,CD38,CD70,CEMIP,CFB,CLEC4E,CRLF2,CXCL10,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,ENPP2,FPR2,GCH1,HESX1,IDO1,IFIT2,IL12B,IL15RA,IL1A,IL1B,IL2RA,IRF7,ISG15,ITGB8,KCNA2,MDK,MN1,NAMPT,NCF1,PAX5,PDE4B,PDPN,PTGES,PTGIR,PTGS2,SLC1A2,SNAI1,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TNIP3,UNC13A,VCAN,WNT5A,ZBP1	57
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Cell movement of monocyte-derived dendritic cells	2.68E-08	CCL19,CCL4,CCL5,CCR7,CD38,CXCL10,FPR2	7
Cell-mediated Immune Response,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Migration of CD4+ T-lymphocytes	2.68E-08	CCL19,CCL20,CCL4,CCL5,CXCL1,CXCL10,IL12B	7
Cellular Movement	Cell movement of lymphoma cell lines	2.82E-08	CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CXCL13,CXCL5,CXCL8	9
Cardiovascular Disease,Connective Tissue Disorders,Dermatological Diseases and Conditions,Immunological Disease,Inflammatory Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Systemic sclerosis	2.84E-08	CCL20,CCL4,CD226,EBI3,FPR2,IL1B,ITGB8,JAK3,PTGIR,THBS1	10
Cancer,Organismal Injury and Abnormalities	Abdominal cancer	2.89E-08	ABTB2,ACOD1,ADAM19,ADGRE1,ADORA2A,AIM2,ANGPTL4,ANKRD22,ANKRD33B,APOBEC3A,APOL3,BTBD11,C1QTNF1,C6orf223,CA12,CALHM6,CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCL8,CCR7,CD300E,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EHF,ENPP2,EPSTI1,EREG,ETV7,FPR2,FSIP1,GBP4,GBP5,GCH1,GFPT2,HAPLN3,HELZ2,HERC5,HESX1,HPN,HS3ST3B1,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,ITGB8,JAK3,KCNA2,KCNJ5,LAD1,LAG3,LAMP3,MAP1LC3A,MCOLN2,MDK,MN1,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,MX1,MX2,MYO1G,NAMPT,NCF1,NKG7,NKX3-1,NSUN7,OASL,PANX2,PAX5,PDE4B,PDPN,PLAC8,PLXNA4,PRAME,PTGES,PTGIR,PTGS2,S100A12,SERPINB2,SIGLEC1,SIGLEC10,SLAMF1,SLC1A2,SLC2A6,SLC38A5,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TNIP3,TRAF1,UNC13A,VCAN,WFDC21P,WNT5A,XAF1,ZBP1	139
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemoattraction of monocytes	2.91E-08	CCL4,CCL5,CXCL10,CXCL8,FPR2	5
Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response,Tissue Development	Accumulation of lymphocytes	2.92E-08	ADORA2A,CCL5,CCR7,CD70,CD80,CXCL10,CXCL3,ENPP2,IL12B,IL2RA,TNFSF10	11
Cellular Movement	Cell movement of muscle cells	2.98E-08	CCL5,CXCL1,CXCL10,CXCL2,CXCL3,CXCL8,ENPP2,NAMPT,PTGIR,PTGS2,THBS1,TNFSF10,VCAN	13
Cellular Movement	Extravasation of myeloid cells	3.10E-08	CCL4,CCL5,CXCL1,CXCL8,IL1B,MDK,TNFAIP6	7
Inflammatory Response	TH1 immune response	3.12E-08	CCL5,CXCL10,CXCL8,EBI3,IL12B,IL1B,NCF1,STAT4	8
Cancer,Organismal Injury and Abnormalities	Non-melanoma solid tumor	3.12E-08	ABTB2,ACOD1,ADAM19,ADGRE1,ADORA2A,AIM2,ANGPTL4,ANKRD22,ANKRD33B,APOBEC3A,APOL3,BCL2L14,BTBD11,C1QTNF1,C6orf223,CA12,CALHM6,CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EHF,ENPP2,EPSTI1,EREG,ETV7,FPR2,FSIP1,G0S2,GBP4,GBP5,GCH1,GFPT2,HAPLN3,HELZ2,HERC5,HESX1,HPN,HS3ST3B1,HSH2D,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,ITGB8,JAK3,KCNA2,KCNJ5,LAD1,LAG3,LAMP3,MAP1LC3A,MCOLN2,MDK,MN1,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,MX1,MX2,MYO1G,NAMPT,NCF1,NKG7,NKX3-1,NSUN7,OASL,PANX2,PAX5,PDE4B,PDPN,PLAC8,PLXNA4,PRAME,PTGES,PTGIR,PTGS2,RSAD2,S100A12,SERPINB2,SIGLEC1,SIGLEC10,SLAMF1,SLC1A2,SLC2A6,SLC38A5,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TNIP3,TRAF1,UNC13A,VCAN,WNT5A,XAF1,ZBP1	144
Cellular Function and Maintenance	Engulfment of leukocytes	3.53E-08	CCL19,CCL5,CCR7,CD38,CXCL10,HSH2D,IL12B,IL1A,IL1B,ISG15,MYO1G,SIGLEC1,THBS1	13
Cancer,Organismal Injury and Abnormalities	Metastasis of tumor cell lines	3.61E-08	ADORA2A,ANGPTL4,CALHM6,CCL8,CXCL1,CXCL2,CXCL3,CXCL5,CXCL8,ENPP2,IL1B,IRF7,ISG15,PTGS2,SNAI1,THBS1,VCAN,WFDC21P,WNT5A	19
Dermatological Diseases and Conditions,Immunological Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	Atopic dermatitis	3.96E-08	CCL20,CCL23,CCL5,CXCL8,IFI27,IL1A,IL1B,IL2RA,JAK3,MX1,PDE4B,PTGS2,SOCS2,TNFSF10	14
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemoattraction of mononuclear leukocytes	4.08E-08	CCL4,CCL5,CXCL10,CXCL13,CXCL8,FPR2	6
Immunological Disease,Inflammatory Disease,Ophthalmic Disease,Organismal Injury and Abnormalities	Experimental autoimmune uveitis	4.08E-08	CCL5,CLEC4E,IL12B,IL1B,SIGLEC1,THBS1	6
Organismal Injury and Abnormalities,Respiratory Disease	Respiratory distress	4.26E-08	CCL5,CCR7,CLEC4E,CMPK2,CXCL10,CXCL8,IL1A,IL1B,JAK3,NAMPT,NCF1,PTGS2,S100A12,STAT4	14
Cellular Movement	Chemotaxis of tumor cell lines	4.53E-08	CCL19,CCL20,CCL23,CCL4,CCL5,CCL8,CXCL1,CXCL13,CXCL3,CXCL8,FPR2	11
Inflammatory Disease,Ophthalmic Disease,Organismal Injury and Abnormalities	Uveitis	4.56E-08	CA12,CCL5,CLEC4E,IL12B,IL1B,JAK3,PTGS2,SIGLEC1,THBS1	9
Cellular Movement	Extravasation of cells	4.56E-08	CCL4,CCL5,CXCL1,CXCL8,ENPP2,IL1B,MDK,TNFAIP6,WNT5A	9
Cellular Function and Maintenance	Engulfment of cells	4.85E-08	ADORA2A,CCL19,CCL4,CCL5,CCR7,CD38,CXCL10,FPR2,HSH2D,IL12B,IL15RA,IL1A,IL1B,IRF7,ISG15,MYO1G,SIGLEC1,SIGLEC10,THBS1,TNFSF10,WNT5A	21
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Migration of monocyte-derived dendritic cells	5.00E-08	CCL19,CCL4,CCL5,CCR7,CD38,FPR2	6
Cell-To-Cell Signaling and Interaction,Cellular Movement,Immune Cell Trafficking	Attraction of lymphocytes	5.00E-08	CCL19,CCL4,CCL5,CXCL10,CXCL13,CXCL8	6
Cancer,Organismal Injury and Abnormalities	Tumorigenesis of tissue	5.08E-08	ABTB2,ACOD1,ADAM19,ADGRE1,ADORA2A,AIM2,ANGPTL4,ANKRD22,ANKRD33B,APOBEC3A,APOL3,BCL2L14,BTBD11,C1QTNF1,C6orf223,CA12,CALHM6,CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EHF,ENPP2,EPSTI1,EREG,ETV7,FPR2,FSIP1,G0S2,GBP4,GBP5,GCH1,GFPT2,HAPLN3,HELZ2,HERC5,HESX1,HPN,HS3ST3B1,HSH2D,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,ITGB8,JAK3,KCNA2,KCNJ5,LAD1,LAG3,LAMP3,MAP1LC3A,MCOLN2,MDK,MN1,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,MX1,MX2,MYO1G,NAMPT,NCF1,NKG7,NKX3-1,NSUN7,OASL,PANX2,PAX5,PDE4B,PDPN,PLXNA4,PRAME,PTGES,PTGIR,PTGS2,RSAD2,S100A12,SERPINB2,SIGLEC1,SIGLEC10,SLAMF1,SLC1A2,SLC2A6,SLC38A5,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TNIP3,TRAF1,UNC13A,VCAN,WNT5A,XAF1,ZBP1	143
Cellular Growth and Proliferation,Hematological System Development and Function	Inhibition of blood cells	5.32E-08	ADORA2A,CCL4,CD80,IDO1,IL27,LAG3,PTGS2,TNFSF10,WNT5A	9
Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders,Tissue Morphology	Damage of cartilage tissue	5.32E-08	CD70,CFB,CXCL8,IL1A,IL1B,NAMPT,PTGIR,PTGS2,TNFAIP6	9
Cancer,Organismal Injury and Abnormalities	Metastasis of cells	5.49E-08	ADORA2A,ANGPTL4,CALHM6,CCL8,CLEC4D,CXCL1,CXCL2,CXCL3,CXCL5,CXCL8,ENPP2,IL1B,IRF7,ISG15,PTGS2,SNAI1,THBS1,VCAN,WFDC21P,WNT5A	20
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Tissue Development	Differentiation of antigen presenting cells	5.49E-08	CXCL10,IL1A,IL1B,IL2RA,IRF4,IRF7,ITGB8,JAK3,MDK,PAX5,PLAC8,SIGLEC10,SOCS3,TNFSF10	14
Cellular Movement	Chemotaxis of germ cell tumor cell lines	5.63E-08	CCL4,CCL5,CXCL3,CXCL8	4
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Attraction of effector lymphocytes	5.63E-08	CCL4,CCL5,CXCL10,CXCL8	4
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Transmigration of neutrophils	5.71E-08	ADORA2A,CXCL1,CXCL2,CXCL3,CXCL5,CXCL8,IL1B,SOCS3	8
Cellular Development,Cellular Growth and Proliferation,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Tissue Development	Development of phagocytes	5.74E-08	CCL23,CXCL3,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ITGB8,JAK3,MDK,PLAC8,SIGLEC10,TNFSF10	15
Cancer,Organismal Injury and Abnormalities	Extraadrenal retroperitoneal tumor	5.90E-08	ABTB2,ADAM19,ADGRE1,ADORA2A,AIM2,APOBEC3A,BTBD11,CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCL8,CCR7,CD70,CEMIP,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,ENPP2,EREG,GBP4,HAPLN3,HELZ2,HERC5,IDO1,IFIT3,IFITM1,IL1A,IL1B,IL2RA,ITGB8,JAK3,MDK,MN1,MT1E,MT1G,MYO1G,NCF1,NSUN7,PDE4B,PLAC8,PLXNA4,PRAME,PTGES,PTGS2,S100A12,SERPINB2,SIGLEC1,SLC1A2,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,UNC13A,VCAN,WNT5A	69
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Mobilization of neutrophils	5.93E-08	CCL4,CXCL2,CXCL3,CXCL8,IL1B	5
Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Respiratory Disease	Asthma	6.13E-08	ADORA2A,CCL5,CRLF2,CXCL10,CXCL8,FPR2,IL12B,IL1B,IL2RA,PDE4B,PDPN,PTGS2,SOCS2,SOCS3,WNT5A	15
Cancer,Organismal Injury and Abnormalities	Intraabdominal organ tumor	6.66E-08	ABTB2,ACOD1,ADAM19,ADGRE1,ADORA2A,AIM2,ANGPTL4,ANKRD22,ANKRD33B,APOBEC3A,BTBD11,C1QTNF1,C6orf223,CA12,CALHM6,CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCL8,CCR7,CD300E,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EHF,ENPP2,EPSTI1,EREG,ETV7,FPR2,FSIP1,GBP4,GBP5,GCH1,GFPT2,HAPLN3,HELZ2,HERC5,HESX1,HPN,HS3ST3B1,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,ITGB8,JAK3,KCNA2,KCNJ5,LAD1,LAG3,LAMP3,MAP1LC3A,MCOLN2,MDK,MN1,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,MX1,MX2,MYO1G,NAMPT,NCF1,NKG7,NKX3-1,NSUN7,OASL,PANX2,PAX5,PDE4B,PDPN,PLAC8,PLXNA4,PRAME,PTGES,PTGIR,PTGS2,S100A12,SERPINB2,SIGLEC1,SIGLEC10,SLAMF1,SLC1A2,SLC2A6,SLC38A5,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TNIP3,TRAF1,UNC13A,VCAN,WFDC21P,WNT5A,XAF1,ZBP1	138
Cancer,Organismal Injury and Abnormalities	Neoplasia of tumor cell lines	6.69E-08	ADORA2A,ANGPTL4,CALHM6,CCL8,CXCL1,CXCL2,CXCL3,CXCL5,CXCL8,ENPP2,EREG,IL1B,IL27,IRF7,ISG15,PTGES,PTGS2,SNAI1,THBS1,VCAN,WFDC21P,WNT5A	22
Cell-To-Cell Signaling and Interaction	Immune response of myeloid cells	6.74E-08	ADORA2A,CD38,CXCL1,CXCL10,CXCL3,CXCL8,DDX58,HSH2D,IL1B,IRF4,ISG15,SIGLEC1,THBS1	13
Hematological Disease,Infectious Diseases,Organismal Injury and Abnormalities	Viral hemorrhagic fever	6.96E-08	CCL4,CCL5,CXCL1,CXCL10,CXCL8,ISG15,KCNJ5	7
Cellular Movement	Migration of tumor cell lines	7.39E-08	ANGPTL4,CCL19,CCL20,CCL4,CCL5,CCR7,CEMIP,CXCL10,CXCL13,CXCL2,CXCL5,CXCL8,DDX58,EBI3,EHF,ENPP2,EREG,FSIP1,IFIT2,IL1A,IL1B,ISG15,MDK,PAX5,PDPN,PTGS2,SNAI1,SOCS3,TNFAIP6,TNFSF10,VCAN,WFDC21P,WNT5A	33
Organismal Injury and Abnormalities,Renal and Urological Disease	Chronic kidney disease	7.41E-08	ADORA2A,CA12,CD80,CXCL8,IDO1,IL1A,IL1B,IL27,IL2RA,PDE4B,PTGIR,PTGS2,SLC2A6,SOCS2,WNT5A	15
Connective Tissue Disorders,Immunological Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Active stage juvenile rheumatoid arthritis	8.17E-08	CD80,IL1A,IL1B,JAK3,PDE4B	5
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Transmigration of dendritic cells	8.17E-08	CCL19,CCL4,CCL5,CCR7,IL1B	5
Infectious Diseases,Organismal Injury and Abnormalities	Infection by Flaviviridae	8.44E-08	CCL20,CCL4,CCL5,CCR7,CXCL10,CXCL8,DDX58,IFITM1,IL7R,ISG20,RSAD2	11
Cellular Function and Maintenance,Hematological System Development and Function	Function of myeloid cells	8.47E-08	AIM2,CCL5,CLEC4E,CXCL10,CXCL8,DDX58,IDO1,IL12B,IL1B,IL27,PTGS2,SLAMF1	12
Cellular Movement	Movement of hematopoietic cell lines	8.93E-08	CCL19,CCL4,CCL5,CCR7,CXCL13,CXCL3,CXCL8,SOCS2,WNT5A	9
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cell rolling of leukocytes	9.11E-08	CCR7,CXCL1,CXCL10,CXCL2,CXCL3,CXCL8,FPR2,IL1B	8
Organismal Injury and Abnormalities,Respiratory Disease	Acute lung injury	9.33E-08	ADORA2A,CCL5,CMPK2,CXCL10,CXCL8,IL1A,IL1B,JAK3,NAMPT,NCF1,PTGS2	11
Infectious Diseases,Organismal Injury and Abnormalities	Infection by Bacilli	9.58E-08	CA12,CXCL10,CXCL2,CXCL3,EBI3,IL12B,IL1B,NCF1,PTGS2	9
Cell-mediated Immune Response,Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Adhesion of T lymphocytes	9.58E-08	CCL19,CCL20,CCL4,CCR7,CD80,IL1B,IL7R,JAK3,THBS1	9
Cardiovascular System Development and Function,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Organismal Development,Tissue Development	Endothelial cell development	9.59E-08	ANGPTL4,CCR7,CXCL1,CXCL10,CXCL2,CXCL8,ENPP2,FPR2,IL1A,IL1B,MDK,PLXNA4,PTGIR,PTGS2,THBS1,TNFSF10,WNT5A	17
Cancer,Organismal Injury and Abnormalities	Growth of malignant tumor	9.84E-08	ADORA2A,CD70,CD80,CXCL1,CXCL3,CXCL5,CXCL8,HPN,IDO1,IL12B,IL1A,IL1B,IRF4,NKX3-1,PTGS2,SNAI1,SOCS3,THBS1,TNFSF10,WNT5A	20
Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Respiratory Disease	Inflammation of airway	9.85E-08	ADORA2A,CCL5,CRLF2,CXCL10,CXCL8,EBI3,FPR2,IL12B,IL1B,IL27,IL2RA,PDE4B,PDPN,PTGS2,SOCS2,SOCS3,WNT5A	17
Cell Signaling,Molecular Transport,Nucleic Acid Metabolism,Small Molecule Biochemistry	Concentration of cyclic AMP	1.01E-07	ADORA2A,ANGPTL4,CCL5,CXCL10,CXCL3,CXCL8,IL1A,IL1B,PTGIR,PTGS2,THBS1,WNT5A	12
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Priming of T lymphocytes	1.01E-07	CD38,CD80,IL12B,IL15RA,IL1B,IRF4,SIGLEC1	7
Cellular Development,Cellular Growth and Proliferation	Colony formation of cells	1.02E-07	ADAM19,CCL23,CCL4,CRLF2,CXCL3,CXCL8,EHF,EREG,HPN,IL1A,IL1B,ISG15,MDK,MT1X,NKX3-1,PAX5,PDPN,PTGES,PTGS2,SOCS2,TNFSF10,VCAN	22
Cell-To-Cell Signaling and Interaction,Inflammatory Response	Immune response of T lymphocytes	1.05E-07	CCR7,CD226,CXCL8,IL12B,IL1B,IL2RA,IL7R,ITGB8,NAMPT,SOCS3	10
Connective Tissue Disorders,Immunological Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Active rheumatoid arthritis	1.05E-07	CD80,IL1A,IL1B,JAK3,PDE4B,PTGS2	6
Cellular Movement	Chemotaxis of carcinoma cell lines	1.10E-07	CCL19,CCL4,CCL5,CXCL3,CXCL8	5
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Cell movement of naive lymphocytes	1.10E-07	CCL19,CCL20,CCL4,CCR7,CXCL13	5
Cardiovascular Disease,Organismal Injury and Abnormalities	Atherosclerosis	1.10E-07	ADORA2A,ANGPTL4,CA12,CXCL10,CXCL2,EREG,IL1A,IL1B,KCNJ5,NCF1,PDE4B,PTGES,PTGIR,PTGS2,RSAD2,SOCS3,THBS1,TNFSF10,VCAN	19
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking	Attraction of memory T lymphocytes	1.12E-07	CCL4,CCL5,CXCL10,CXCL8	4
Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	Hemophagocytic lymphohistiocytosis	1.13E-07	CXCL2,CXCL3,IL1A,IL1B,IL2RA,SERPINB2,TNFSF10	7
Cell-To-Cell Signaling and Interaction	Communication of cells	1.14E-07	ADGRE1,ADORA2A,BTBD11,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD226,CD70,CRLF2,CXCL1,CXCL10,CXCL13,CXCL5,CXCL8,DDX58,FPR2,IFITM1,IL12B,IL1B,IL2RA,IL7R,JAK3,LAG3,MX1,NAMPT,PDPN,SIGLEC10,SLAMF1,SOCS2,SOCS3,TAMALIN,THBS1,TNFAIP6,TNFSF10,WNT5A	38
Cellular Movement	Migration of cancer cells	1.14E-07	CCL19,CCL5,CCR7,CXCL10,CXCL13,CXCL8,NKX3-1,PTGS2,SNAI1,THBS1,VCAN,WNT5A	12
Cancer,Organismal Injury and Abnormalities	Breast or pancreatic cancer	1.17E-07	ABTB2,ADAM19,ADGRE1,ADORA2A,AIM2,ANGPTL4,APOBEC3A,BTBD11,CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCL8,CCR7,CD300E,CD70,CD80,CEMIP,CFB,CMPK2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,ENPP2,EPSTI1,EREG,FPR2,G0S2,GFPT2,HAPLN3,HELZ2,HERC5,HPN,IDO1,IFI27,IFI44L,IFIT1,IFIT3,IFITM1,IL12B,IL1A,IL1B,IL2RA,IRF7,ITGB8,JAK3,LAD1,MCOLN2,MDK,MN1,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,MX1,MYO1G,NAMPT,NSUN7,PDPN,PLAC8,PLXNA4,PRAME,PTGES,PTGS2,RSAD2,SIGLEC1,SLC1A2,SLC8A3,SLCO5A1,SNAI1,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,UNC13A,VCAN,WNT5A	87
Neurological Disease,Organismal Injury and Abnormalities	Progressive motor neuropathy	1.24E-07	ADORA2A,CCL5,CD38,CXCL1,EPSTI1,GCH1,IDO1,IFIT1,IL1A,IL1B,IL2RA,IL7R,IRF4,IRF7,ISG15,KCNA2,LAG3,MN1,MX1,PDE4B,PTGS2,RSAD2,SLC1A2,UNC13A	24
Cellular Movement,Hematological System Development and Function	Mobilization of myeloid cells	1.25E-07	CCL4,CXCL10,CXCL2,CXCL3,CXCL8,IL1B	6
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Influx of neutrophils	1.27E-07	CCL4,CXCL1,CXCL2,CXCL5,IL1B,IRF4,IRF7	7
Cancer,Organismal Injury and Abnormalities	Malignant solid tumor	1.30E-07	ABTB2,ACOD1,ADAM19,ADGRE1,ADORA2A,AIM2,ANGPTL4,ANKRD22,ANKRD33B,APOBEC3A,APOL3,BCL2L14,BTBD11,C1QTNF1,C6orf223,CA12,CALHM6,CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EHF,ENPP2,EPSTI1,EREG,ETV7,FPR2,FSIP1,G0S2,GBP4,GBP5,GCH1,GFPT2,HAPLN3,HELZ2,HERC5,HESX1,HPN,HS3ST3B1,HSH2D,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,ITGB8,JAK3,KCNA2,KCNJ5,LAD1,LAG3,LAMP3,MAP1LC3A,MCOLN2,MDK,MN1,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,MX1,MX2,MYO1G,NAMPT,NCF1,NKG7,NKX3-1,NSUN7,OASL,PANX2,PAX5,PDE4B,PDPN,PLAC8,PLXNA4,PRAME,PTGES,PTGIR,PTGS2,RSAD2,S100A12,SERPINB2,SIGLEC1,SIGLEC10,SLAMF1,SLC1A2,SLC2A6,SLC38A5,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TNIP3,TRAF1,UNC13A,VCAN,WFDC21P,WNT5A,XAF1,ZBP1	145
Cancer,Organismal Injury and Abnormalities	Carcinoma	1.32E-07	ABTB2,ACOD1,ADAM19,ADGRE1,ADORA2A,AIM2,ANGPTL4,ANKRD22,ANKRD33B,APOBEC3A,APOL3,BTBD11,C1QTNF1,C6orf223,CA12,CALHM6,CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EHF,ENPP2,EPSTI1,EREG,ETV7,FPR2,FSIP1,G0S2,GBP4,GBP5,GCH1,GFPT2,HAPLN3,HELZ2,HERC5,HESX1,HPN,HS3ST3B1,HSH2D,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,ITGB8,JAK3,KCNA2,KCNJ5,LAD1,LAG3,LAMP3,MAP1LC3A,MCOLN2,MDK,MN1,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,MX1,MX2,MYO1G,NAMPT,NCF1,NKG7,NKX3-1,NSUN7,OASL,PANX2,PAX5,PDE4B,PDPN,PLXNA4,PRAME,PTGES,PTGIR,PTGS2,RSAD2,S100A12,SERPINB2,SIGLEC1,SIGLEC10,SLAMF1,SLC1A2,SLC2A6,SLC38A5,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TNIP3,TRAF1,UNC13A,VCAN,WNT5A,XAF1,ZBP1	142
Cancer,Organismal Injury and Abnormalities	Malignant neoplasm of retroperitoneum	1.37E-07	ABTB2,ADAM19,ADGRE1,ADORA2A,AIM2,BTBD11,CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCL8,CCR7,CD70,CEMIP,CMPK2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,DDX58,ENPP2,EREG,HAPLN3,HELZ2,HERC5,IDO1,IFIT3,IFITM1,IL1A,IL1B,IL2RA,ITGB8,JAK3,MDK,MN1,MT1E,MT1G,MYO1G,NCF1,NSUN7,PDE4B,PLAC8,PLXNA4,PRAME,PTGES,PTGS2,S100A12,SERPINB2,SIGLEC1,SLC1A2,SLC8A3,SLCO5A1,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,UNC13A,VCAN,WNT5A	64
Cell-To-Cell Signaling and Interaction,Cellular Growth and Proliferation,Hematological System Development and Function	Stimulation of lymphocytes	1.39E-07	CCL19,CD70,CD80,CLEC4E,CXCL10,IL12B,IL1B,IL27,SLAMF1,TNFSF10	10
Cancer,Cellular Development,Cellular Growth and Proliferation,Organismal Injury and Abnormalities,Tumor Morphology	Proliferation of tumor cells	1.41E-07	CA12,CD70,CXCL1,CXCL3,CXCL8,GCH1,HPN,IDO1,IL1A,IL1B,IRF4,NKX3-1,PTGS2,SNAI1,SOCS3,THBS1,TNFSF10,VCAN,WNT5A	19
Cancer,Organismal Injury and Abnormalities	Primary solid tumor	1.43E-07	ADAM19,CCL19,CXCL13,CXCL8,DDX58,EBI3,IDO1,IFI27,IL1B,IL2RA,IRF4,JAK3,PLAC8,PRAME,PTGS2,SNAI1,VCAN,WNT5A	18
Infectious Diseases,Organismal Injury and Abnormalities	Replication of Murine herpesvirus 4	1.46E-07	CXCL10,CXCL3,DDX58,ISG20,MX2	5
Connective Tissue Disorders,Organismal Injury and Abnormalities,Tissue Morphology	Deterioration of connective tissue	1.46E-07	CD70,CD80,CFB,CXCL3,CXCL8,IL12B,IL1A,IL1B,NAMPT,PTGIR,PTGS2,TNFAIP6	12
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Cell movement of peripheral blood monocytes	1.48E-07	CCL19,CCL4,CCL5,CCL8,CXCL8,FPR2	6
Cellular Movement,Hematological System Development and Function,Hypersensitivity Response,Immune Cell Trafficking	Migration of eosinophils	1.48E-07	CCL4,CCL5,CXCL10,CXCL2,CXCL8,IL1B	6
Cellular Movement	Mobilization of cells	1.54E-07	CCL20,CCL4,CXCL10,CXCL2,CXCL3,CXCL8,IL1B,SOCS3	8
Tissue Morphology	Quantity of progenitor cells	1.54E-07	CCR7,CD226,CD70,CD80,CRLF2,CXCL8,IL12B,IL15RA,IL1A,IL1B,IL7R,IRF4,JAK3,LAG3,SOCS3,STAT4,THBS1,WNT5A	18
Cancer,Endocrine System Disorders,Gastrointestinal Disease,Organismal Injury and Abnormalities	Pancreatic tumor	1.54E-07	ABTB2,ADGRE1,AIM2,APOBEC3A,BTBD11,CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCL8,CCR7,CD70,CEMIP,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,ENPP2,EREG,GBP4,HELZ2,HERC5,IDO1,IFITM1,IL1A,IL1B,ITGB8,JAK3,MDK,MN1,MT1G,MYO1G,NSUN7,PLAC8,PLXNA4,PTGES,PTGS2,SIGLEC1,SLC1A2,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFSF10,UNC13A,VCAN,WNT5A	56
Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders	Disorder of basal ganglia	1.61E-07	ADGRE1,ADORA2A,CA12,CCL4,CCL5,CD38,CXCL10,DDX58,ENPP2,GCH1,IDO1,IFIT3,IL1A,IL1B,IRF7,ISG15,JAK3,MT1E,MT1G,MT1H,MT1M,MT1X,MT2A,PDE4B,PTGS2,SLC1A2,VCAN,ZBP1	28
Cancer,Organismal Injury and Abnormalities	Nonhematologic malignant neoplasm	1.73E-07	ABTB2,ACOD1,ADAM19,ADGRE1,ADORA2A,AIM2,ANGPTL4,ANKRD22,ANKRD33B,APOBEC3A,APOL3,BCL2L14,BTBD11,C1QTNF1,C6orf223,CA12,CALHM6,CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCL8,CCR7,CD226,CD300E,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EHF,ENPP2,EPSTI1,EREG,ETV7,FPR2,FSIP1,G0S2,GBP4,GBP5,GCH1,GFPT2,HAPLN3,HELZ2,HERC5,HESX1,HPN,HS3ST3B1,HSH2D,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL15RA,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ISG20,ITGB8,JAK3,KCNA2,KCNJ5,LAD1,LAG3,LAMP3,MAP1LC3A,MCOLN2,MDK,MN1,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,MX1,MX2,MYO1G,NAMPT,NCF1,NKG7,NKX3-1,NSUN7,OASL,PANX2,PAX5,PDE4B,PDPN,PLXNA4,PRAME,PTGES,PTGIR,PTGS2,RSAD2,S100A12,SERPINB2,SIGLEC1,SIGLEC10,SLAMF1,SLC1A2,SLC2A6,SLC38A5,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TNIP3,TRAF1,UNC13A,VCAN,WNT5A,XAF1,ZBP1	143
Immunological Disease,Organismal Injury and Abnormalities	Primary immunodeficiency disorder	1.82E-07	CD70,IFI27,IFIT1,IL12B,IL2RA,IL7R,IRF4,JAK3,MX1,NCF1,NCF1C	11
Digestive System Development and Function,Gastrointestinal Disease,Hepatic System Development and Function,Hepatic System Disease,Infectious Diseases,Inflammatory Disease,Inflammatory Response,Organ Development,Organismal Injury and Abnormalities	Viral hepatitis	1.82E-07	CCL20,CCL4,CCL5,CCR7,CXCL10,CXCL8,DDX58,GBP5,IL1B,IL2RA,IL7R	11
Cancer,Organismal Injury and Abnormalities	Abdominal carcinoma	1.83E-07	ABTB2,ACOD1,ADAM19,ADGRE1,ADORA2A,AIM2,ANGPTL4,ANKRD22,ANKRD33B,APOBEC3A,APOL3,BTBD11,C1QTNF1,C6orf223,CA12,CALHM6,CCL19,CCL20,CCL4,CCL4L1/CCL4L2,CCL5,CCL8,CCR7,CD300E,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EHF,ENPP2,EPSTI1,EREG,ETV7,FPR2,FSIP1,GBP4,GBP5,GCH1,GFPT2,HAPLN3,HELZ2,HERC5,HESX1,HPN,HS3ST3B1,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ITGB8,JAK3,KCNA2,KCNJ5,LAD1,LAG3,LAMP3,MAP1LC3A,MCOLN2,MDK,MN1,MT1E,MT1G,MT1H,MT1M,MT1X,MT2A,MX1,MX2,MYO1G,NAMPT,NCF1,NKG7,NKX3-1,NSUN7,OASL,PANX2,PAX5,PDE4B,PDPN,PLXNA4,PRAME,PTGES,PTGIR,PTGS2,S100A12,SERPINB2,SIGLEC1,SIGLEC10,SLAMF1,SLC1A2,SLC2A6,SLC38A5,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TNIP3,TRAF1,UNC13A,VCAN,WNT5A,XAF1,ZBP1	135
Gastrointestinal Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities	Severe enteritis	1.91E-07	CCR7,CD80,IL12B,JAK3,PTGS2	5
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemoattraction of neutrophils	1.91E-07	CXCL1,CXCL10,CXCL3,CXCL5,CXCL8	5
Cellular Movement,Skeletal and Muscular System Development and Function	Migration of airway smooth muscle cells	2.01E-07	CXCL1,CXCL2,CXCL3,CXCL8	4
Lipid Metabolism,Small Molecule Biochemistry	Conversion of prostaglandin h2	2.01E-07	CYP2E1,IL1B,PTGES,PTGS2	4
Immunological Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Renal and Urological Disease	Systemic lupus erythematosus nephritis	2.03E-07	CD80,EPSTI1,HERC5,IRF7,ISG20,PTGS2	6
Neurological Disease,Organismal Injury and Abnormalities	Neurological signs	2.03E-07	ADGRE1,ADORA2A,CA12,CCL4,CCL5,CD38,CXCL10,DDX58,ENPP2,IDO1,IFIT3,IL15RA,IRF7,ISG15,KCNA2,MN1,MT1E,MT1G,MT1H,MT1M,MT1X,MT2A,PTGES,PTGS2,SLC1A2,VCAN,ZBP1	27
Cancer,Organismal Injury and Abnormalities	Adenocarcinoma	2.12E-07	ABTB2,ADAM19,ADGRE1,ADORA2A,AIM2,ANGPTL4,ANKRD22,ANKRD33B,APOBEC3A,APOL3,BTBD11,C1QTNF1,C6orf223,CA12,CALHM6,CCL19,CCL20,CCL4,CCL5,CCL8,CCR7,CD300E,CD38,CD70,CD80,CEMIP,CFB,CLEC4D,CLEC4E,CMPK2,CRLF2,CXCL1,CXCL10,CXCL13,CXCL2,CXCL3,CXCL5,CXCL8,CYP2E1,DDX58,EBI3,EHF,ENPP2,EPSTI1,EREG,FPR2,FSIP1,G0S2,GBP4,GBP5,GFPT2,HAPLN3,HELZ2,HERC5,HESX1,HPN,HS3ST3B1,IDO1,IFI27,IFI44L,IFIT1,IFIT2,IFIT3,IFITM1,IL12B,IL1A,IL1B,IL27,IL2RA,IL7R,IRF4,IRF7,ISG15,ITGB8,JAK3,KCNA2,KCNJ5,LAD1,LAG3,LAMP3,MAP1LC3A,MCOLN2,MDK,MN1,MT1E,MT1F,MT1G,MT1H,MT1X,MT2A,MX1,MX2,MYO1G,NAMPT,NCF1,NKG7,NKX3-1,NSUN7,PANX2,PAX5,PDE4B,PDPN,PLXNA4,PRAME,PTGES,PTGIR,PTGS2,RSAD2,S100A12,SERPINB2,SIGLEC1,SIGLEC10,SLAMF1,SLC1A2,SLC2A6,SLC38A5,SLC8A3,SLCO5A1,SNAI1,SOCS2,SOCS3,STAT4,THBS1,TNFAIP6,TNFSF10,TNIP3,TRAF1,UNC13A,VCAN,WNT5A,XAF1,ZBP1	132
Cardiovascular Disease,Organismal Injury and Abnormalities	Vascular lesion	2.37E-07	ADORA2A,ANGPTL4,CXCL10,CXCL2,IDO1,IL1A,IL1B,NCF1,PTGES,PTGS2,S100A12,SOCS3,THBS1,TNFSF10,VCAN	15
Cell Death and Survival,Organismal Injury and Abnormalities	Cell viability of phagocytes	2.44E-07	CCL4,CCR7,CD38,IL1B,IRF4,MX1,SERPINB2,TNFSF10,WNT5A	9
Inflammatory Disease,Organismal Injury and Abnormalities,Respiratory Disease	Acute respiratory distress syndrome	2.44E-07	CCL5,CMPK2,CXCL10,CXCL8,IL1A,IL1B,JAK3,NAMPT,PTGS2	9
Cellular Movement	Emigration of cells	2.46E-07	CCL19,CCR7,CXCL1,CXCL2,CXCL3,FPR2,IL1B	7
Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Inflammatory Response	Immune response of neutrophils	2.50E-07	ADORA2A,CCL20,CCL4,CXCL1,CXCL10,CXCL3,CXCL8,THBS1	8
Cardiovascular Disease,Organismal Injury and Abnormalities	Occlusion of artery	2.66E-07	ADORA2A,ANGPTL4,CA12,CXCL10,CXCL2,CXCL8,EREG,IL1A,IL1B,KCNJ5,NCF1,PDE4B,PTGES,PTGIR,PTGS2,RSAD2,SOCS3,THBS1,TNFSF10,VCAN	20
Cellular Development,Cellular Growth and Proliferation	Proliferation of leukemia cell lines	2.69E-07	CRLF2,IL15RA,IL1A,IL1B,IL2RA,JAK3,NKX3-1,PAX5,PRAME,PTGS2,SERPINB2,SOCS3,TNFSF10,WNT5A	14
Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities	Peripheral T-cell lymphoma	2.70E-07	ADAM19,C1QTNF1,CCL19,CCL20,CCR7,CXCL13,IFI44L,IFIT2,IFIT3,IL2RA,ISG15,JAK3,LAD1	13
Cell-mediated Immune Response,Cellular Development,Cellular Function and Maintenance,Cellular Growth and Proliferation,Embryonic Development,Hematological System Development and Function,Hematopoiesis,Lymphoid Tissue Structure and Development,Organ Development,Organismal Development,Tissue Development	Differentiation of Th2 cells	2.70E-07	CCL5,CD80,IL12B,IRF4,JAK3,RSAD2,SOCS2,STAT4	8
Connective Tissue Disorders,Dermatological Diseases and Conditions,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Psoriatic arthritis	2.70E-07	CD80,CXCL8,IL12B,IL1B,JAK3,PDE4B,PTGS2,S100A12	8
Gastrointestinal Disease,Hepatic System Disease,Organismal Injury and Abnormalities	Fibrosis of liver	2.73E-07	ADORA2A,CCL4,CCL8,CCR7,CD38,CD80,CXCL8,GBP5,IL1A,IL7R,NAMPT,NCF1,SOCS3,TNFSF10,WNT5A	15
Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response,Tissue Development	Accumulation of granulocytes	2.94E-07	CCL5,CXCL1,CXCL10,CXCL2,CXCL3,CXCL8,IL1B,NCF1,TNFSF10	9
Cancer,Hematological Disease,Organismal Injury and Abnormalities	Growth of hematological system tumor	2.94E-07	CD70,CD80,IL1A,IL1B,IRF4,NKX3-1,PTGS2,TNFSF10,WNT5A	9
Connective Tissue Disorders,Inflammatory Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders	Spondylitis	2.94E-07	CD80,IL12B,IL1B,JAK3,PAX5,PTGS2,S100A12,SLC1A2,TNFSF10	9
Embryonic Development,Organismal Development	Development of body trunk	2.99E-07	ADAM19,C1QTNF1,CCL19,CCL5,CCR7,CD38,CD80,CXCL10,CXCL13,CXCL3,EREG,HPN,HS3ST3B1,IL12B,IL1A,IL1B,IL27,IL7R,JAK3,MDK,NCF1,NKX3-1,PAX5,PDPN,PTGES,PTGS2,SNAI1,SOCS2,SOCS3,THBS1,TNFSF10,VCAN,WNT5A	33
Cellular Movement	Invasion of cells	3.08E-07	ANGPTL4,CCL19,CCR7,CD226,CXCL1,CXCL10,CXCL2,CXCL5,CXCL8,DDX58,ENPP2,EPSTI1,EREG,FSIP1,GFPT2,HPN,IFIT2,IFITM1,IL1B,ISG15,ITGB8,MDK,MX1,NAMPT,PAX5,PTGS2,S100A12,SNAI1,THBS1,TNFAIP6,TNFSF10,VCAN,WFDC21P,WNT5A	34
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemotaxis of macrophages	3.12E-07	CCL4,CCL5,CXCL10,FPR2,IL12B,MDK,PTGES,SLAMF1,THBS1	9
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response,Lymphoid Tissue Structure and Development	Chemoattraction of lymphocytes	3.13E-07	CCL4,CCL5,CXCL10,CXCL13,CXCL8	5
Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemotaxis of monocyte-derived dendritic cells	3.13E-07	CCL19,CCL5,CCR7,CD38,CXCL10	5
Hematological Disease,Hereditary Disorder,Immunological Disease,Organismal Injury and Abnormalities	Familial hemophagocytic lymphohistiocytosis	3.17E-07	CXCL2,CXCL3,IL1A,IL1B,SERPINB2,TNFSF10	6
Immunological Disease,Organismal Injury and Abnormalities	Immunodeficiency	3.31E-07	CD70,CFB,GFPT2,IFI27,IFIT1,IL12B,IL2RA,IL7R,IRF4,IRF7,ISG15,JAK3,MX1,NCF1,NCF1C	15
Cell-To-Cell Signaling and Interaction,Cellular Movement,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response	Chemoattraction of macrophages	3.33E-07	CCL4,CCL5,CXCL10,IL12B	4
Cellular Development,Cellular Growth and Proliferation,Organ Development,Skeletal and Muscular System Development and Function,Tissue Development	Proliferation of smooth muscle cells	3.42E-07	CCL5,CXCL8,EREG,IL12B,IL1A,IL1B,NAMPT,NCF1,PTGIR,PTGS2,SOCS3,THBS1,TNFSF10,VCAN	14
